TitleGenColors Logo

Gene list

Applied filters:

COG category: Cell wall/membrane biogenesis
Gene type: CDS
Genomic element: chromosome I

Number of genes found: 172

Free access
Sort by:

 



# Vibrio fischeri ES114, ES114

>VF1394 glycine betaine transporter
MSTNSKQTSDKLVPTLTIGFILLFLLAAFVDLSAFTATIQSLFMSVSTMF
GYWWQWLMIITFVLAFIIAMSSYGKIKMGSESKPTIGTFRWVAMIMCTLL
AGGGVFWSAAEPIFHFITPSPSFSDVKGGTLAAVAPALSQSFLHWGFLAW
AVLGTLSTIVLMYAHYNCGVKLRPRALLYPILGDKLENHWIGSVIDACSI
IAVAAGTIGPIGFLATQLSYSLTVLTGLESSLMSQIIILTVIVSIYSVSA
FSGMDKGLQWLSRMNVIGAVALLVAILVLGPTGFIFKEFGMAFGTYIQHL
PEMSLSTADPSWNSWWTWFFWGWFIGFAPMMAIFIARISQGRSIRELIIT
VAIIAPIATNFWFSSLGGTGIFLELQTPGSISQPLQEAGLPAVLLASLAQ
LPFSFLLIPAFLVLTTTFVATTGDSMAYSIAMAVEGTDTPSRYQRLFWAV
MMGVVAGVLLIAGDGGLNALQSFIVITAVPVSFLVGVTFITGPIAVLRMK
SAELESKSSVDCTKSVTV
>VF0265 UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl- meso-diaminopimelate ligase
MHIHILGICGTFMGGAATLARQLGHKVTGCDANVYPPMSTLLESQGIEII
EGFDPSQLDPAPDLVVIGNAMSRGNPCVEYVLDKNLKYTSGPQWLQEFLL
QDRWVMAVAGTHGKTTTSSMLAWVLEECGYKPGFLVGGVLGNFGESARLG
ESMFFVVEADEYDSAFFDKRSKFVHYRPRTLVLNNLEFDHADIFDDLAAI
QRQFHHLIRTVPSTGRIFAPKQDKPLEQVLEQGCWSELEFTGEDGQWKAI
KLQKDGSQFDVYFEGENVGQVNWDLVGDHNVSNALMVVASARHVGVTPDL
ACEALGKFINTKRRLELKGEVNGVTVYDDFAHHPTAIDLTLNGLRNKVGD
KKIIAVLEPRSSTMKLGVHKDTLAASLHAADSVYLYQPDNIAWSVDDVAQ
QCTQPAHTHNNIDAFVDMIVNEAQPGDQILVMSNGGFEGIHGKLLSGLGD
AVKHIEMVD
>VF2199 cell division protein FtsQ
MIKAVKMNTSFDKEKVRKHLPGAIFLSLVVITSLWLVISTISWMTDEDRL
PLSHMIIQGQLKHITADDIREAIDSMDSIGTFMTQDVNKLQDALLSLPWI
AQVSVRKQWPETIKVFVVEHQPEATWNNRVIVNPEGVVFNAPMSDLREPK
PALFGLKPAVKMYLIFGTNCKAI
>VF1105 transporter
MLIKLAWRNLWRQKRRTILTASALALALLLSLLMRSIQEGSYTANIENAA
RLSTGLIQLQNPEFKETQSIDDLLPMSDDFIAPTKQQPNIQFTLPRIETF
SLAAAKDKSKGVLVVGVDPQPENTYSSLADKVVQGAYFTATDKSVLLSEG
LARYFQLNVGDEIVLYGQGYRGQTAAGLYVIKGIVHFPMPDLNNQLIYLP
IQEAVQLFSTENQVTSWVLHTRDFSLLPQTVDNLQKGYGQVVSVRPWNDL
SPEMEQQIQIDRVSGIIMMYILYGIVGFGLFATLLMMTLERQREFGVMLA
TGMVRFRLLKLLVIESFFIGLLGILLGLVIAIPVLGYLYINPITLTGETA
KAMLEMGYDPVIPVLISGWLFINQMLIVTGLLLLCLLYPLWRVYHLDIVT
ALKGGSHAA
>VF0184 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase
MSKELIRSQIADLVDQYAALEYAPKEFVGGETVVPPSGKVLGANELKMMV
EASLDGWLTTGRFNDAFEKRLGEYLGVPYVLTTTSGSSANLLALTALTSP
KLGDRQLKPGDEVITVAAGFPTTVNPTIQNGLIPVFVDVDIPTYQIKPDM
IEAAVTEKTKAIMVAHTLGNVFDLTEARRVADKYNLWLIEDCCDALGSTY
NDQMVGTFGDISTVSFYPAHHITMGEGGAVFTKDKELRKLIESFRDWGRD
CYCAPGCDDTCKKRFDQQLGSLPQGYDHKYTYSHLGYNLKITDMQAACGL
AQMDRVEELVQARKDNYAYLKEGLASCEEFIILPEATENSTPSWFGFPIT
IKEDSGIERVDLLKFMDQFKIGTRLLFAGNLTRQPYFKDVEYRVVGELTN
TDLIMNNTFWIGVYPGLTKDHLDFVIEKFEEFFGVSF
>VF2203 UDP-N-acetylmuramoylalanine--D-glutamateligase
MIDTRDTPPGHDQLPENVELHSGGWQQDWLINADLIVTNPGIALASPQLK
PAIDKGIKIVGDIELFAWAVNAPVIAITGSNGKSTVTDLTGEMAKAAGVK
TAVGGNIGFAALDLLEQDAELYVLELSSFQLETTSTLKLKAAAFLNLSED
HMDRYQGMADYRQAKLRIFEHAEVCIVNRDDKQTYPDVEKTLKSFGFDQG
DYGCIEKDGIEYLAKNTVPLLAANELGLVGKHNIANSLVAIALLDAAGIN
LDATLDTLRTYNGLTHRCQVVADNNGIRWVNDSKATNVASTLAALSGLQL
EGKLHLLVGGVGKGADFSELSPALHDLNLMMYCFGEDGDQFVSLDPRSLL
CETMNEAIATLYPTLNKGDMVMLSPACASFDQYANFMARGDAFTQLAKQY
SIES
>VF0195 UDP-N-acetyl-D-quinovosamine 4-epimerase
MNILLTGGFGFIGQQVVKLSPIKRKVVRMGESYSGSSVHQIDTLSTTTNW
QGAFTDINAIIHLAGLAHSNSFSEQDYQEVNVDGTLHLANEAAKSGVKRF
VFVSSIGVNGTSTYQTPFSSLSKVEPHSAYAQSKYDAEVGLQKIAEETGL
EVVIVRPTLVYGPNAPGNFGALTRLVNKVPVLPFGLVNNKRDFISVQNLA
DLLITCANDPKAAGRTFLASDGQVVSIKDFTNAIAKGLNKRVIQLPIPVW
CMRLAGKLLGKEVMIEQLVGNLEVDSSNAQEVLGWIPPYTMQQAMHSLLE
NNK
>VF0352 undecaprenyl-phosphatebeta-glucosephosphotransferase
MPRSDMKQQNIKMISDSYRTLTKAFDFIAINLLLTSILSFHGLEETAVDL
SAGLLFSTIFLLISEYSGLYTINTKVELKKYLLRLTFSLLLTVSVFFILK
LRLASLEGMQISNLNSHIYLLWYVCVWGGLSLSRTLCTLSYTYIVIPRLK
INKIAIIGLTPAGLSIEQALISKYKNQKISIEFYDDRSSSRFSYVNKSGY
AGKVSELIEKVKNDEIQSVYIALPMVAKDRIKDIIHQLSNSTVNAYIVPD
LYTYKLSVSQIKRIGNVHTFSIFSSPFEGLGAVIKRIEDIVIGSLITLLI
LPVLCIVALGVKLSSPGPILFKQDRYGLGGKKIKVWKFRSMKVMENSEVV
TQATKNDPRVTRFGSFIRRTSLDELPQFINVLQGSMSIVGPRPHAVAHNE
EYRVLVDNYMVRHKIKPGITGLAQINGYRGETDTLDKMEKRVEYDIKYLQ
NWSLSMDLKIIFLTVFKGFVSDTAY
>VF0176 2-dehydro-3-deoxyphosphooctonate aldolase
MFLIAGPCVIESEDLVLDTFAQLQEMTNKLGIEYIAKSSFTKANRSSASA
FTGPGLEEGLKILQKAKDQLGVKIITDVHEDTPLDEVASVVDVLQTPAFL
VRQTGFIQRVASMGKPVNIKKGQWMHPADMAPVVEKCRAVGNDDIWLCDR
GTSFGFGALVNYMPGLTIMKETGCKVVMDATHSVQMPGMLNGSTGGNRLH
VPAIARAAVAVGIDGLFMETHPDPDKALCDGPNMLPLKHMEELLETLLEI
DEVVHRRAFIESKLV
>VF0332 outer membrane protein
MIKKLPLFIIVCLLAISSQALAETELEIEGLEGPLLSNVEAYISGIPEED
YSVSLRFQARLQESITDALKALGYYQSTTTFVVEGDTSDRTLLVNIDAGQ
PVIIYVSDIVISGEAAADEDFINAVDNSGLNLGQVINHGRYESLKSTLQN
LALRKGYFDGDFTTNRLEIAPGRHQAIVRIHYDSGKRYSFGETSIDGSQI
EEKRVRSIIPFQAGDPYLASQVGELNQYLSNTEWFSSVYVEPDIDAVGKT
YQLPMKVHLSPQVRNQLETSIGYATDVGARGKIRWKKPWLNPEGHSLDTA
LSISKPEQEATISYKIPLEQVLKDYYVVKYGLKNVDNNDTDSLESNLAFE
RHWVYDSGWHRTIYTRFLYEEFTQGVQDGTAWLVLPGISFSKSRSRGGTM
PMWGDKKAFTIEATDQALTSDVKLLRLQAQGAIVRSIGENHRGVARADIG
AIYTDDFYKLPPSIRFFAGGDNSIRGYGYEEVSPKDSEGYLTGGQYMATA
SLEYQYRVVGNWWVATFVDYGDAWLDTPDWKMGTGVGIRWASPVGPVRLD
FAWGLDAEPGDEFKIHFTLGPEV
>VF0131 phosphoglycerol transferase MdoB and related proteins, alkaline phosphatase superfamily
MNFQQNYKQLSRAIWLSVFIAVIILSVGRLVFLANIVDTAELAQREGDLW
RALFTGFRFDLKVVVIGFAPLLLIGLSVAAFPKMYRIFSKVFPWYSGLIF
FLVTGFSIGNYYYYLTYGSYIDVFIFGLADDDTKAVLANAWADYPIFLSF
ISSLIVACCCAAFIRTIIKKMQQWEWKTPHKITTSVSVFMMILTVFFFAR
GTLGSHPLKRYHAQVSDYKVLNSITPNGIIALEWANSDYKKQNKFHTVSK
AELEDQFTKVVGNTTGEFTTSKNTYLANNKPHVVMALMEGMGTNVLVEDD
YPQNDLLGALRPAFESDFVFKRFLAETPATINSLVNMLGQSNVPTISHSS
AQKVEVAAAAARPYKNAGYKTLFITATNGMWRNVANYLPAQGFDEILDEN
AILKAFPEAEAFRGEWGLSDEYAFKLAEKELNEATQPLMIYILTITNHTP
YEVPKNYDVKPLKVSKQLVERMQKGEEEAMRLLETYQYANNALGEFIANV
KQSPLGDSTLIAAAGDHKLRGFTMKYPDDIAIMNAVPFYLYVPEKIQQYV
PYLYDEKRVGSHKDIFPTLYAFSLSEAAYYSLGGENMLSTTDTSRFGYNP
EMTVVEQGMYLNSQPEKLYQWRSELETSLEPTSNDKPNVDKDYHTLQTLY
INGQVKGVH
>VF0752 rare lipoprotein B precursor
MTSACGFHLRGDYLLPDEVHEISLTSFDQYSSLTRDVQKQLRMNGIRQVA
PTTVTPSLDLISESLNERTLSLYQNSRAAEKELTYNVSYSVLIPGHDLKT
YTTTVNRNYLDNPLTALAKSVERDMIEEEMRAQAAEQILRQMARLKADDA
PVETSDVITHDDETESKVTTKEVIKSMSTTAETTQ
>VF0174 beta-D-GlcNAc beta-1,3-galactosyltransferase
MNSYPLISVIMSVYKEEREWLVSSIQSILDQTVSDFEFIIILDFPNSELL
KTLKDFEKKDSRIIIYQNEKNVGLVESLNTALSFSRGKYIARMDADDISH
KNRFEKQLKYITLNNLDLVGGNVNIFHSNKGIYNTTDKVQSDYFLCKLLK
IGTIGIVHPTFFSKRNVYDTIGGYYHAECAEDLELLMRANLNGFKIGNIP
DVILDCRYSEKSITKENAYFMFCTVKYLKSLYRSSLKSGDYKFNSNYIEL
YLYDENNKLAFSEKQNLMSEARHSFNEKKYISFLINLIKSILISRTVFFS
IKVNVMSFLFRKVEVKIPKVLLACIKIKLQ
>VF0166 dTDP-glucose 4,6-dehydratase
MKILVTGGAGFIGSAVVRHIINNTQDSVINLDKLTYAGNLESLSDVDSDE
RYVFEQVDICDGAELDRVFSEHKPDAVMHLAAESHVDRSIDGPAAFIETN
IVGTYTLLEATRSYWNTLSDDKKQAFRFHHISTDEVYGDLEGTDDLFTET
TSYEPSSPYSASKASSDHLVRAWLRTYGLPTIVTNCSNNYGPYHFPEKLI
PLMILNALDGKSLPIYGNGMQIRDWLFVEDHARALYKVVTEGVVGETYNI
GGHNEKANIDVVKTICSLLEELVPNKPEGVAQYLDLITYVTDRPGHDVRY
AIDASKIERELGWKPEETFESGIRKTVEWYLDNKQWWSRVLDGSYAGERL
GVYSESAVIEKEAK
>VF0315 opacity associated proteins OapA
MNKKKKMNVKRPDFSEQLANLKEKCGPLIEKVAPYWQRLPQFHQKALRIL
VPVTFVLILLPSGAEEEVDSIQPTVIPAPEMQRQSVSLNLEGLSEQEASS
NRNQRETRVNREEKVPTQTASIEKETTAVEAKWHDYQIQEGDTLYQVFRK
NNLPLTELNKVVKIEGADKPLSNIKKGQLFRFKLNRQGDLDIVQIERDGQ
AIMYFRMSDGNFGRSK
>VF1953 outer membrane protein OmpH
MILKKLVKVAALGAVLVSGSFFANAAEAATKVGYVNMAQIVQQMPQREAI
SEKLRAEFKDRIDELRGLESKIKDKVETIKRDGELLGASGKTKLEREIAS
LQSDYKLKAQALDEDNRRRQGEERQKLIMQVQQTVEKVANKEGYDMVVDA
ATLLWAKPEDNLSEKVIKAIK
>VF0134 alpha-L-glycero-D-manno-heptosebeta-1,4-glucosyl transferase
MTHSSTPTLAVALIVKNEAKHLQACLETVQGWVDEIVILDSGSTDETESI
ARQFTDRFFVNTEWPGFGKQRQLAQQYVTADYVLWLDADERVTPELKEDI
LTAVKANKPNVAYKINRLSSAFGKFIKHSGWSPDWVVRLYKVNDMAYNDA
LVHESVSVPDGVQVAPLSGRLLHFTYDVLHQYNAKNVMYIKSWVDQREGK
KKGSLSGAFFHGFFCFIRMYILKRGFLDGRHGLLLAMLSASVTFNRYADL
WLRDYNKSNKE
>VF0374 rod shape-determining protein MreD
MASSHLMRGRVIIWLSFLIALTLQAAPWPGALEVLRPSWIILVTFYWVLA
LPHRVNVGTAMVLGILWDLLLGTTLGIRGMTMAILVYLVAANFKVLRNLA
LWQQAAIFSGLTLLGKVLEFMGEFLVHDVSFNAHFLWAGVLNFLLWPWLF
LLMRRVRRHWSIR
>VF0135 ADP-heptose--LPS heptosyltransferase III
MPLFTSAPHSLCILRLSAIGDVCHAIAAVQTIQTTWPSTKITWIVGKVEA
QLIHDLPGITVIPFDKKLGLAGMRTIWHQLKDQQFDALVHMQLALRASLL
TVGIKAKYKVGFNRKRAKEGQWLFTNRKIEDTASAHVLDSFYAFIEYLGV
PKREPSWNIPLSEVDLAFIDTHVSSEKPYVVISPAASKDERNWLTERYAQ
LADWLNEQGYQVVLCGSPSEREKQLGAAIESLAQSPLINIIGLTSLKQLT
AVLKKATVVIAPDSGPAHIATTQHTPVIGLYGHSNPKRTGPYNSLPYVVS
VYEHHVTQQQNKPIEDLKWSTRVKGDHIMQDITLDMVKEAFLRLRHQ
>VF0735 alanine racemase
MKFTKCALALSLALPSIANSAPLLSLDTLTNQEKIQQTNAWLEIDTQAFQ
NNIDTLRASLEQDTKVCAIMKADAYGNGIEGLMASVIERNVECIGITSNE
EARIVRAKGFVGELMRVRAASPNEIESGLQYKIEELIGSSEQANIIAKLA
KQNNTIIPVHLALNAGGMGRNGLDLSQPQGKKEALNIAFNGHVNIVGIMT
HFPNESVDEIRTKLNLFKQESQWLIDEAQLNRDDITLHVANSYTTINLPE
AHLDMVRPGGLLYGDMPNNPEYKRIVQFKTSVASLNYLPKGSTIGYSSTY
VLGRDSILANLPLGYSDGYVRSIGNNGYVLINGQKANVVGVTSMNTTMVD
ITDIKNVQPGDEVVLFGKQNEFTIEAKEMEAFSSRSMPELYVIWGSTNPK
IYK
>VF1141 beta-glucosidase
MDKQFKGFGLTISHVSALSGGLTNACLKVEAKEGSFVWRPISLQAKILGA
DRAKEHEILQALSDESFSPNVYGENEEGILVEWLEGEVIALDKAQDVAVD
LLCSVHQISLDKLSEQIKNKPMSLKDRIIDYWNSITPENQTPEMEAYFEY
FSQQDEQAFFSHCLCHYDIGAYNIVVKEDGYGLIDWEYASMGDPSQDLTS
MIIANQFDMDDVISLYCQKRRLNIDEWKRAVIHWTPWVTFMGALWFSLGY
QLLKNTCYQELAEREMCKLIKLLPSIHK
>VF0418 diacylglycerol kinase
MTDVPSGKPGNTGIKRIIKATGFSIQGLKAAFKHEAAVRQEFAMLVIATP
IALLLDVTVD
>VF2372 glucosamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGAVAQRDVAEILVEGLRRLEYRGYDSAGVAVVDAEHNYTRIRRLG
KVKELADAVETAHVVGGTGIAHTRWATHGEPSEVNAHPHVSGDITLVHNG
IIENHESLRTLLQERGYIFESQTDTEVIAHLVEWELRSSGSLLEAVQKTA
TQLEGAYGTVVMDRREPERLVVARSGSPIVIGCGVGENFLASDQLALLNV
TRRFMYLEEGDVAEITRREIRVFDARGEQVERAITESNAEHDAGDKGQYR
HFMQKEVFEQPKALINTMEGRITNDSVVTESIGVNAVEILNKVEHVQIIA
CGTSYNAGMTARYWFESLAGVSCDVEIASEFRYRKFVTRPNSLLITLSQS
GETADTLAALRLAKERGYMGAMTVCNVAGSSLVRESDFAFMTRAGTEIGV
ASTKAFTTQLAALLMLVTALGKQQNRISKEKEKEIVEALHALPAQIEQAL
SFDKEIEALAPDFADKHHTLFLGRGEFYPIAVEASLKLKEISYIHAEAYA
AGELKHGPLALIDAEMPVVVVAPTNDLLEKLKSNVEEVRARGGLLYVFAD
EQAGFEADESMKIITMPHVSDITAPIYYTIPMQLLSYHVALIKGTDVDQP
RNLAKAVTVE
>VF1166 hypothetical protein
MFNFVEPPNAFYDFENILTQDEWQKKQGWFKDKITELNSDVIGFQEVFSP
NALKALVDELGYAYFCTVDEPKSEDGYVFNSPVVAFASRYPILNAQPVIA
EQTQLERFGIEFEFNRIPVHASIELPHLGITDCYVVHFKSQRPKEPEVNN
EIDEESLSSLNQLHNEQLGSWLSTAQRGLEANILHNHIIQQRKKTNQAIV
VMGDFNKPLFHDEFKGLLSHELRFDKFSSDYLAQFQLKDSWNLYGKLKGI
DLLEERTYTHYYGAKGSVLDYILLSNEFDSSFSGNILEVVDYTVTDKHIV
NPTFDIDQFSTDHALVSITARIRQA
>VF0186 dTDP-glucose 4,6-dehydratase
MSNILMINKNDLELISDKVESSFGLFKNKNIFITGGTGFFGKWLLEAILY
LNLKRNLNITVTLLSRDPERFKNNYPHLCSSDNISFIKGDVRDFPFPNEY
FNYIIHAATEASSTLNKENPSLMRSTIMDGAKHICNFANTVKCERLLYTS
SGAAYGPQPPNMKAMSEDFIINPNFNVNDAYSSAKLESEDFFKNNLKCQI
IVARCFAFSGPYLPLDGSYAFGNFIRDALDGKNISLNGDGTAVRSYLYAA
DLVIWLMKALVIGQDRTIYNIGSPDPITTLKLAEKICDASGNNSSVNVLN
KSSDSGNIYIPCTLKSQSDLDVEVYTSIDESILKTLKFYR
>VF1950 acyl-[acyl-carrier-protein]--UDP-N- acetylglucosamine O-acyltransferase
MIHETAKIHPSAVIEGNVTIEANVSVGPFTYISGNVTIGEGTEVMSHVVI
KGDTTIGKDNRIFAFAIIGEESQDKKYGGEATTVVIGDRNVIRESVQIHR
GTVQDRGVTTVGSDNLLCVNVHIAHDCVVGDNIIMGNNATLAGHVTVEDF
AIVSALSPVHQFCTVGAHSFIGGASVVVQDVPPFVMAQGNHCKPFGINIE
GLKRRGFEKAEIHAIRRAYKALYRNGNTLEEAKVEINKEIEAFPVLQGFL
DLFEKSTRGIIR
>VF1556 phospholipase A1
MKKWMLLIALAIPSLSFAKELNRIHAYEDSYILGSYISDLNKQTYIDGGF
EDADGLHDVEVKFKFSFAVPLFPVSQSSSIMFAYTQKSLWQLGNSDISSP
FRETNYKPQFFLMHQSNMLIFNNAEFGYMHESNGQTASLSRSWDRIYGAL
ERIDGPVQYGVRAWYVIADEENNEDITDYLGNYDVWASVGNDIGTLSTRF
HYNFETDKGGAELGYTLNVNKFVGLYVQAWKGYGETLIDYNHDQTRIGLG
IKLMPPN
>VF1539 transporter
MLRIFIFFITLGFGSLAFAEEAQSIDNLQQFASLIRWSGVAFSFVIVFVA
WLLLRFTQSIVDGISSQFAQRRMLMQKLQSFFQFFIYMSTGMAVFMLSFR
VDERVLALIGGTIAVSVGFALKDLTASFIAGLTVMIDRPFQVGDRVTFEG
NYGDIIAIGLRSVRMQTLNDDIITIPNNKFLNEVAVSGNYGALDMQVVIP
FYIGMDQDINTARDIIQEAASSSRYIHLPKPVVVLVKQTITDNYLAIQLT
CKAYVVDIKFEKLFETDITLRVMQEFRKSDIFPPAIAVQNK
>VF0474 D-alanyl-meso-diaminopimelate endopeptidase
MFFSRYSLIALSLISFSSIADIKETLSSLPSGSRTAITVENLQSNKIEFQ
QKQDELLPPASTLKIATALAARLALGTEFTFTTTLYKADKDVVLTFSGDP
SLSRKQLSELFDDSELKTIQGDLWIDGSIFTGYERAVGWPWDILGVCYSA
PSSALSIDENCVQASITTHEDGSTRVFVPIHQPISFSSYAKSVSREEQKS
TFCDLELTTQGNHYELNGCLVRRNKPLPLKFAVQDTRDFTKRTVSKILAE
HNIKLNGEIHFGAPKSELTNLNVLANHNSKPLMELLDHMLKKSDNHYADN
LTKMLGHLNYQQPGSFTNGTAAIKDILLKQADIDLSNAVLVDGSGLSRNN
RMTANQMKSILQFIHKYDKELGLIELLPTSGIDGTLKYRNSMRKEPIKGS
MKSKSGSLFGSYNMAGFVGLENKEPQLFVQFVADYHPVVAKEGTIPVERP
IDSFEKSFYQELIKLSQE
>VF2207 division specific D,D-transpeptidase
MKLPNRKKNNKRITKAPPTFIQWRFGVIVFFVFLALAILIARAAYIQVIE
PDNLVKQGDMRSIRVKSLPSARGIISDRNDEQLAVSVPVDAVWADPVTIY
KEGGLAEIERWYALADVLGLKRKELISKIEKNKKRRFIYLQRQISPAVAA
YIKKLKLAGIGLKAESRRYYPTGEISAHVIGVTGIDSHGLEGVERSYDGW
LTGEPGRRTVRKDRYGRVVENISLKEKQEGKPLTLSIDQRLQAIAYRAIK
QAVSDFRAMSGSVVMIDIKTGEVLAMVNAPSYNPNNREQLQSFRMRNRVI
TDTLEPGSTVKPFVVLAALDGGTANLDTIIDTGNGIMRIGGSRVRDSSKV
GKADLTTILKKSSNIGVAHLALGMPLQELLAEYAAVGLADPSGLNLIGEA
TGIFPDRRRWSDFEIATLAFGYGLSVTPIQLAHAYATLGAYGEYRPLSIL
KTTGPTPGKQVVNRQHAKAVLEMMETVTQPGGTATRAAVPGYRVAAKTGT
SRKAVRGGYSDEYMTVTAGVAPVSNPRIALVTIVNQPQGDEYYAGQVAAP
IFGQVMKDALQILNVAPDESTVKHIDVLN
>VF1481 penicillin binding protein transpeptidase
MSKQKTPFRNHQFETSLFNQRVIVAFLFMLVAIGGLVFNLYHLQVRNHDR
YQVRSNRNRIKIIPVAPNRGLIYDRNGVVLAQNIPVSTLELTPAKIDDIN
ATLTSLQKLLNLSDHDIAKFKKLMHRTRSTKPITLIEQMSEVQIAKFSVN
QFHYNGTNINAYLERYYPYGESLTHVLGYVGKINDRDIRTLKKDNRYTNY
EGTHAIGKLGIELYYESTLHGKSGYQKVEINSHGRIVRTLDYVAPIPGKD
IKLNIDLGLQLYAYNQLKIKKENPITHKMEDYHRRGSIVVLDPRDDSVLA
MVSSPSYDPNLFVHGISSKHYNALLNNPDLPLLNRTTLGIYPPGSTVKPQ
IAVAALSEKVITPNTTTNFPGWWRIPHSKSRKFRDDIRWGHGEVNVVKAI
EKSVDTFFYQVAYDMGIDRLSTWMNKFGYGKPSGIDIREESPANMPTRDW
KHSNYHQAWYKGDTIPVGIGQGYWTATPMQIAKATAVIADEGIVHRPHLL
KSVMEDGKFKPIIFKDFPKVNHTKKQYWNLAKEGMHRVIVSGTARKLFQN
LAYKAGGKTGTSQVFGLDKGEEYNSEDVAEHLRDHALFTSFAPLDKPKVL
VAAVLENAGWGKYAAPIGRNIMDYVLINPKISLDHT
>VF2159 serine protease
MRFKPFIFSSVFLYLFSSTAVASDESRPKIGLVLAGGGAKGAAHIGVLKA
LEEMHIPVDYITGTSMGAYVGGLYASGMSADEIEAFIDTVDWNSGFVDKV
ERSERQIRDKEYEDRYQIGTDIGFSFTELKAPKGFVQGQTMAKILRTTSD
NIPYLNSFDQLPIPFRAVATDIEKLEPVVLDKGNLAEAMMASMSVPGALP
PAEYDGRLLVDGGVVNNMPVDVVREMGADIVIAVDIGSDYLEADDISSYL
SVMGQLTNFMVKNSTKQQEKLLGDKDILLAPHVGKMETAEFDKMPFAYGK
GYDIAYEKHKALDKLVLSDEKYQEYLKEKEIKASTLLRGEDLYVNKITIK
NDSLYTESMLLDRLNLEEGRSYSADELEEHIRDLYVIDRFERVDYYYQEN
EEGTHDLIVEVKEKSWGPNYLDFRFALEDDFDNQSKYSLGMSINFTDIEL
TGLRDNRSELRTNFELGTDKLVSAELYTPFLVNQLLFTSFKSVYSVEQKK
FSLSGNELGSIDNDFPLEYSDLVFEGAVGLQGHLWSDFRIGGRYTKGKVA
FTSLRDLNASYSREGIFAQYRLDTLDNFTFPTKGFYVKAEYLYSHDNVED
SVVDIEATKDSVIEISLNTRAAWTYSRHTFVGNFEYGVVENKKGDLQLEP
KSLGGFLRLSGTPKDSLTGQNLIFGSLVYRYRLMDNDFGLFQSPIYLGAS
LENGGLWNQDSIKDAPLYTAGSAFIGVDSPIGPIVLAYGRTEQNHESVYL
SIGAVL
>VF1547 aspartate racemase
MNKKLGILGGMGPLATVEFMLKIISQTPAHNDQEHIPMVVSSVPQIPDRT
AFIMGHGQDPYPELKHSFEQLERSGAECIVIPCNTAHYWYPQLSATSHVH
TISIIDSVVQEAQNRRYKTVGLLATTATMKARMYQQKLNQYHIEVIETDD
IQQRDVMQGIYEVKAGNVEKGKALMLPVFESMLAQGAEAVILGCTEIPVA
LAEQNLKQPQQCLDSLEILAKCCVDWSYEEQAALAS
>VF0988 hypothetical protein
MSQLTATALFISSLSLLSFSSLAAEPSADDGAFSGDAKIGFIYTKTDETS
MSVNSGATLKYEEALWHHKAAFSTYYTKGNESDDGTNKNKTVYDVKYDMT
DSLFVFGNAKYEHDQFATYREQVLLVSGFGATLIDSSNSKLDVGAGPGYR
YSKRQAFDEDLPNNSEDEVIANLFIEGDSKITDGLELGGGVRMDYGESNT
TTTTHVYLKNKLMESLSLLIDAEYIYNSVVATGKEHDEIYSTISLNYDF
>VF1710 outer membrane protein Slp precursor
MKQVIYFLSVLLLVGCSSLPQELKSTQATTLVEYNAFSDAANAGEKAEVR
LGGVIARLDNLSDQTRIEIVNLPISSVGKPDISEEPNGRFVVYVNGFIDP
VTYAKGRLITVIGQADGIEQANVGEFVYPFPVIQASAIHLWQIQEYVVTN
DLDMDYMPCAGARCFHQRSHLETRRGKVVQEVK
>VF1246 putative omptin family serine protease
MKQLIFILTPLVLISEAMAESDKKDISLGLSLGVLNGASKELVYDDTGRK
LSQLDWRIDNVPIIKLETDWNINQRWTLTGDFWSILIDDGNAHMEDRDWF
IENQHFPTDISISPKTTLKKAYQASLHTTYWLFIQNNYEIGALGGFQYNQ
FKWEDLGGTYSYNNGTDVGTFPDVVGIDYKQEFGMFYAGLTGKYRLDNSE
FSFLLKLSPWVKAKDVDNHYLRNLTFYEKSNEYSDAVSLSINYNYNFGPN
MNLYTEYAYTRYFEANADMTKVNNKTNDSSFSENAAGLDNLYSTLSIGLK
YSF
>VF0745 D-alanyl-D-alanine serine-type carboxypeptidase
MKNSAKQLKRLILSSFILGSTVAVAAPAVIPNAPQIAAKGYVLMDYHSGK
VLAEKDMNVRMNPASLTKMMTSYVIGQEIESGNISMDDDVVISKNAWAKN
FPGSSKMFIEVGSTVKVRELNKGIIIQSGNDACVAMAEHVAGSEDAFVDL
MNAWAKTLNLKNTHFANVHGLDRDDLYSTPYDMALIGQALIRDVPEEYRV
YSEKSFTYNGITQYNRNGLLWDKSMNVDGIKTGHTNGAGFNLVSSATEGK
MRLVAVVMGTKSGNARKAESKKLLNYGFRFFETVSPHKANETFVTEKVWM
GSTDEVALGVAEDTYVTLPRGQAKKMTASFVLEKTLEAPIYKGDVVGKLY
YQIDGEDIAEYPLLALNDVEEGGIFSRLIDYIVLMFKGWLS
>VF0141 UDP-bacillosamine synthetase
MSKTPLVEFVRNIYQTNDFIPLHAPTFDGNEQKYVLETIQSTFVSSVGKF
VDEFEQKIETYTGTAKAVATVNGTAALHAALYMAGVQHGDFVITQALTFV
ATCNALHHMGAEPIFVDVSPVSLGLCPKAMDEYLTQHAQVTDTGCVHKQT
KRPIRAAVPMHTFGHPVELDELIAVCHKWNITLVEDAAESLGSFYKGKHT
GTLGDFGAVSFNGNKIITTGGGGMVLCKSAELGARTKHVTTTAKVPHPYE
FYHDEAGFNYRMPNLNAALGCAQMEILETYLAQKKALANHYQEFFAESDF
QFVVEPEYAQSNYWLNAVICPSAQARDDLLKQTNESGVMTRPIWQLMHRL
PMFKDAPRGDLTQSEHIEAHLINLPSTPIAL
>VF1949 lipid-A-disaccharide synthase
MTKPLRIGIVAGELSGDTLGEGFIKSIKAQYPDAEFVGIGGPKMIAQGCD
SLFDMEELAVMGLVEVLGRLPRLLKVKAELVRYFTQNPPDVFIGIDAPDF
NLRLEKTLKDNGIKTVHYVSPSVWAWRPKRIFKIDAATDLVLAFLPFEKA
FYDKYNVACEFIGHTLADAIPMETDKIAARDLLGLEQEREWLAVLPGSRG
GEVALIAKPFIETCQRIHKQHPNMGFVVAAVNEKRREQFETIWKATAPEL
DFVIIQDTARNVMTAADAVLLASGTVALECMLVKRPMVVGYQVNKLTGWI
AQKLSITEFVSLPNVLAGKELVQEFIQEECHPDFLYPAMEKVLNNDNREL
IEKFTEMHQWIRKDADKQAANAVLRLINKETAE
>VF0906 outer-membrane lipoproteins carrier protein
MKKFLFSLCLLSSTVLASPQSELTERLNQNAGFEAGFTQKVLSPEGDVLM
QGEGDVKILRPNLFRWHTQTPDENLLVTDGNTLWYYNPFVEQVTLMGLEK
ATTQTPFVLLTRNKASDWDNYSVSQNGDAFTVSPKADSAVKSEFIVRIQE
NGKVTGFSVVEQDGQRSDFDFTKFEAKKPAKDNFTFAIPDGVDIDDQR
>VF1411 probable lipoprotein NlpC precursor
MLIPVKFIQNSYLHFLYRLVMFRHLFAIFTVVGLLGCSSTPPVAELSKQE
ITTQHPQLSSSDAYQDYFYQWQGVPYKYGGTSKNGVDCSAFTQNAFDVLH
RLSLPRTTEYQATSGTQIALANAKKGDLIFFKTSVKVRHVGVYIGNREFM
HASTSKGVIISSLDNPYWKKAFWQVRRVL
>VF1632 hypothetical outer membrane protein
MACDYVQSYAVLLILWLYKVVIVSKLISRSVFCLLVLFNSSANAKISQWS
LGAAAAYSPSFYKETPSNATIIPMVGYEGEHLFLRGFSGGYRLKPVGSPQ
NIIFRFVYDPRTFKPNDSNDAAMQKLDERKSTVLGGMSYQMVTHIGIIEL
TGGTDVGRTHNGLYAEAAWRLPIRGRGWAITPSLGYSYNSEKLNNHLYGV
SNEEALRTGVDQFNADWDGQFFIGLSTYFHITPNVRVTGGLRYVNLEGNL
ENSPMIEHTTSSTGSVGIVYVF
>VF1104 hypothetical protein
MKKKIKLIIKIVLFLAFVGVVGHVFAAEPMSADKVVAKSDEQMRGKSSYS
EITMNIIRPDWTRSMSMKSWTKEQNLSLVLITGPAKDKGNASLKRDKEMW
SWIPSIERVIKIAPSMLGQSWMGSDFTNDDLINQSSIVVDYDHKFVKEET
IDGDKTWVIDAIAKPDAPVVWSKVRLWISQKTFIQRKVESYDEFDELVNT
MTTYDIQEMGNRMIATRMVMIPADKPENKTEMITHKAQFNFLINDEFFSQ
MQMKALRY
>VF0175 glycosyltransferase
MYKDKVAVIMSVYKSDNPIDFNVAVNSIIRQTLKCDIFIYQDGPVSRELK
SAINRFRKFNNIFIFVSEENKGLAYALNYLIDSCLLNNYQYIARMDSDDI
SHKNRMSIQVNFLEDNSDIHVVGSYCKEFGADCSLAEKKLPITHNDLLNF
SITRCPFIHPSVMFRTSIFYNGLRYPVNTKYTEDMAFWFILLDLGYKFEN
IPETLIDYRMTENTVLRRRGFDKALSEVFIRFKYMIKFKKITVKNVSFII
GRFVFHLLPPNAIKYLYKKMR
>VF2200 UDP-N-acetylmuramate--alanine ligase
MTKEQKLQLAEIRTMIPEMRRVECIHFVGIGGAGMSGIAEVLLNEGYHIS
GSDMAENTVTVRLAQKGAEIFFGHQASNVAKASVVVVSTAIDPSNPEIVA
AKENRIPVIRRAEMLAELMRYRHGIAVAGTHGKTTTTALTTQIYSEAGLD
PTFVNGGLVKNAGTNARLGSSRFLIAEADESDASFLHLQPMVSIVTNIEA
DHMDTYGGDFETLKQTFIDFLHNLPFYGQAVMCVDDPVVRELLPQVSRQV
ITYGFSDDADVRLINYRQVGQQSFFTVQRKDRTDLDIVLNIPGKHNALNA
TAAIAVATEEDVEDEAILTALLNFEGAGRRFDQLGEFETGNGSAMLVDDY
GHHPTEVDVTIKAARAGWAEKRLVMIFQPHRYSRTRDLYDDFANVLDNVD
VLIMLDVYSAGETPIAGADGRALCRTIRGRGKIDPVFVPTIEALPPVLAN
IIQEGDLILTQGAGDVGKLAKQLASMELNIETMKKLG
>VF0162 putative polysaccharide export protein YccZ precursor
MFMSKTHRSLASALLLVMLSGCTVFPGSHISTSDKNKVEEEQSEDNQNAY
SSDINVYELTPQKVADYQVKQASAQANLELEEQVASYEYRVGPGDILNVT
IWDHPELTIPAGSYRSSSESGNWVHADGTIFYPYIGTVEVEGKTVREIRT
EIAQKLRKFIESPQVDVNVAAFRSKKAYVTGEVDKPGQQAITNIPLTLLD
AVNRSGGLGEDADWRNVTLTRNGKEETLSLYALMQRGDLTQNRLLQSGDI
IHVPRNDTQKVFVMGEVKDPKLLKMDRSGMSLTEALSSVGGINELSADAT
GVFVIRSSSPDKKQESMADIYQLNIKDASALIIGTEFDLKPYDIVYVTAA
PITRWNRLIMQLMPTITGFNELTEGALRVKNWP
>VF0772 2-dehydro-3-deoxyphosphooctonate aldolase
MQNQKTVKIGNIDVANDKPFTLFAGMNVLESRDLAMQICEKYVEVTDRLG
IPYVFKASFDKANRSSVHSYRGPGMEEGLKIFQELKDTFGVKIITDIHTE
AQAQPVADVVDVIQLPAFLARQTDLVEAMAKTGAVINVKKPQFMSPDQVG
NIIDKFSECGNENIILCERGSCMGYDNLVVDMLGFGVMKKASNGSPIIFD
VTHSLQNRDPSGKASGGRRSQTVELAKAGLATGIAGLFIEAHPNPDKALC
DGPSALPLDQLEPFLKQMKSLDDLIKGFEHIDIK
>VF1918 dihydrodipicolinate synthase
MFSGSIVALVTPLDTDGEVDYNSLKSLVDYHIKAGTNGIVAVGTTGESAT
LSVEEHVKLVMKTLEFADGRIPVIAGTGANATHEAVTFSKLFHDSGVAGC
LSVTPYYNKPTQEGLFQHYKAISEATDIPQILYNVPGRTAVDLLPETVAR
LAELDNIVALKDATGDLDRVAITRELCGENFIQLSGDDATALDFVKLGGH
GVISVTSNIAAKDMATMFALAAQGKFEEAEIINQRLMPLHNDLFVEANPI
PVKWAAHRLGMITHSDIRLPLTELSLSAQPTVEQALKSAGLLK
>VF0587 membrane-bound lytic murein transglycosylase A
MFRKLSFVCVLLGLAGCADQPTDRAQQYLDGGFSSNLNKVGEINSDKPSD
FSAFKKQSAEVLERSESMSLRYEELYVQLQKWIDESSNPAELSNYGIQFA
QMGGGDKKGNVMFTGYFSPVIEMRHTPNETFKYPVYDKPDCGSDCPTRAE
INAGALAGLGLELGYADNMIDPFIMEVQGSGFVHFGDDDKLEYFAYGGKN
NHPYVSIGRILIERGEVERKDMSLKAIKEWVAKNDEATVRELLETNPSYV
FFSPKEAHHVLGTAGIPLHAGAAVAADRTLLPMGTPILAEVPQLDKDGKW
TGKHVLKVLLALDTGGAVKENHLDQYYGMGTEAGIAAGHFKHFGRVWKLG
LQDTETENPWEMPKSE
>VF0138 3-deoxy-D-manno-octulosonic-acid transferase
MIRLIYSLFLALLSPLLLYSLYKKKDGKPAFGRRWKEHFGCTPSLNTTQA
PVWIHAVSVGEAIAAAPIIKTLKKQTPEQPILVTTTTSTGAEQIEKLGDL
VEHRYMPIDFCFAVRGFLKATKPEKMLIMETELWPNTLHTVAKFGIPISV
LNARLSEKSFLGYKKVQPIFNLLGKHLTHVCCQYKDDADRFVALGIQPEK
VHVTGSVKFDIEITEQIQASGGILRKQLGEDRPIWIATSTHKGEDEQVLA
AHRSLLHKIPNALLILVPRHPERFNSVFELCQSADFKTVKRTSNQTLTPN
CQIYLGDTMGEMLTLIGASDICFMGGSLLGNKVGGHNLLEPAALAKPSIT
GPSYYNFLEIAETLIKEDATKVIISAEELANLLEQLMTQPEYAEKMGKNA
QSFISKNSGAVIKTLNIV
>VF1751 AsmA
MKKIALLISIPFIAVIGAVLVLVLLVNPNEFKPLITEQVEAQTGRQLTID
GDIEWRFFPSIGFSIGKMALSNPEGFVEPNLVSFDNAILDLNVRPLFQQE
VSIGLITLDGASFTLHTLKNGVTNLDGLVAKKETSTVENNNPTAPAEETD
VNPEASSATSTEFNGWKVSLQGIALTNAEVLIQDDKAGSKIHFSDMNLSL
SQFIPGQWAKLNFDLKGDLGKQKVALKGKTELNIAETLDDASFKNVEFNA
SYADAVNKFNDITFTIDQFSFDKWANLVLKVKGKANNLEVNSNSTFALYV
PKALDLIKIKEFTSTNNVKGKGIPNEDVTAVIGFNSSFALNKSFLKIDKL
ALSAVDTDFTGKLSVQLNDIPKVRFDLRSPSIDVDALLATLPKDESSKTV
DSTTSTKASSTPVKEVEPDLSALKTLDVAGSIIIDKFKANNAKMQNVTSV
FSVNRGVLKLTKFHSDLYSGGIDMTATLDARKSVPTYSVKQTIKGVKVAP
LLTDVMGESLVEGTGNIAINASGKSLKPTALKQNLKGKVSINFADGAVNG
INIPLLIRTTYAKIKGEKVKGSEEAEKTDFSALTADFYLANGNATTKNIK
MVSPLLRIHGEGSAHYVNETANMLIKTSIVGTLKGQGGKDIDDLKDVTIP
IRVTGSWTNPKYKLEFDDVMKQKAQKEIDRGIEKLEEKYGDKIKDEKVKD
AANKLLKGLFN
>VF1182 acriflavin resistance periplasmic protein
MFKKTAIAAVLGSILLAGCDSKEPSIAEPDSRPAKILTVSVGDHETSRLF
PAKAEAGDKAVLAFRVPGQLNTLNVHAGQSVSKGELLATINPDEYRLIQK
QAQAQYRLIDVQYQRIKKLRKDKVVSEQDYDTAVANRKTAKASLDQASAN
LSYTKLVAPYDGTISLLPTENFEYVNAKQSIMHIQTNDILYVVFQLPDYL
LQRFSFTDVSATVSFDSFPNTTFPLEFEEIDTEADRKTSSYTVKMSMPRP
KDLGVLPGMSGQVKVTIPKGGSEKLPLSAIDQDGDTTYVWRVKEDGIVEK
VAVKLNEKRQVVSGIEDSDQIVSSGITGLEEGMKVRKWVKERGL
>VF0183 CDP-glucose 4,6-dehydratase
MNPSFWKGKKVFVTGHSGFKGGWLSLWLQEMGAIVKGYSLPAPTLPSLFE
EAKVGSRMSNEVGDIRDFTHLRQVISEFKPEIVFHMAAQPLVRLSYDDPM
ETYSTNVMGTVYLLEAVKQVGGVKAVVNITSDKCYENREWVWGYREDEAM
GGYDPYSNSKGCAELVASSYRQSFFNKDKYAEHGCALASVRAGNVIGGGD
WADDRLIPDMLKAFSSNQAVEIRSPHAIRPWQHVLEPLSGYITIAEYLYE
YGCDFAEGWNFGPKDEDAKPVEWIVDTLTSVWGDDARWFLSEGEHPHEAH
YLKLDCSKAKMRLNWQPVWDLEYTLTKIVNWQKAWLNKQDMQQYTINEIK
EYMTARAGTK
>VF0168 dTDP-4-dehydrorhamnose 3,5-epimerase
MDIIKTKLADCIIIKPKVFGDERGFFLETFHSQRYKEVAGIKEQFVQDNR
SQSSKNVLRGLHFQKTKPQGKLVTVISGEVFDVAVDLRPESETFGQYEAV
VLSGDNKLQFYVPPGFAHGFCVLSESADFQYKCTDYYDPDDESGLLWSDP
IINIQWPLKTPLLSEKDKIQPLLSEIEAKIKEGWV
>VF0122 Lipid A biosynthesis lauroyl acyltransferase
MSKYPAPKFSSALLHPKYWGVWFGFGFLFAIVTLLPYKVTYKLGRSLGLL
GLKLGKSRAHVARRNLELAFPEMESSEREAIIVENFKNSGLAIFETAMAW
VWPDWRVEKHFSYENKQHILDLAEEGRGVLVVCVHALNLELTARAFTSFA
PGYGVYRPHNNPAYDFIQHWGRTNNGNQMIDRKDVKGMLRVLRKGERLWY
MPDHDYNRNKSVFVPFFAVPDACTTVGSDILISASKCAVVTASGFRTYNN
YHLQIDNDISDQFPKKDPVGVATVMNKAVERVILRCIPQWMWLHKRFKTM
EDPNVKKGIRYD
>VF1869 peptidoglycan hydrolase FlgJ
MQSVKMNNSVNMTDVGFIHDVGGLDKLRKSAVSGDQDSQDKALRAAAEQF
ESIFTQMLFKSMRNANDSFKSDMMSSDNQQFFEQMRDDQMATELSKKGSL
GLADMIVAQLGASMNQAAPVQSGNNLEQDARMAMRKAATDETLRLPADYS
YPHASQAKQESQTEAPEIAQIDKMLAARKVQPADKFETPQDFVNTMKPYA
EKAAKALGVDSNLLIAQAALETGWGKKVIKNSVDSSHNLFNIKADRSWQG
DKISKNTLEYHDNIAVTENAAFRSYDNYEESFSDFVRFLNQNPRYERALQ
QTDSSESFIKGIHSAGYATDPNYSNKVMSVMRKVESLLK
>VF2233 type I secretion outer membrane protein
MRKLLPLFIGMALGSFSSLAAADDLAQVYNQAKENDPQLLRAAATKDAAF
EAVNSSQSSLLPQIDLTAGYNILRSDNDTRDNDRLTAGINLSQELYQQSS
WVSLDIAEKSARQADSAYAAEQQGVILRVAQAYFDVLRANDNLEFVRAEK
AAVARQLEQTKQRFDVGLSAITDVHDAQAQYDSVLANEVLTENQLVNSYE
DLRVITGQGHTHLSVLDTKRFSASPSEQSSDSLIEEAQEKNLSLLAARIS
ADVAKDNISLASSGHMPSLTFDAGYNYTDQSGTKNGFNDDSYGDINAGIN
LYIPLYTGGNTSSLTSQAEFQYVAASQELEATYRDVTKNVRAFNNNINAS
IGALKAYEQTVISAQSALEATEAGFDVGTRTIVDVLDSTRRLYDANRNLA
NARYDYIISVLQLKQAVGTLSEQDIMDINMGLKANKTTQTK
>VF1085 hypothetical protein
MPPTFPSQFINENPMKKIALLLVLFSAFSNANDNISGFYLGAGLGATTFD
DGGAFDYTGASINADDSTLKFMGGYQFNRIVAVELQYTKYGDINVNHPTA
KAAGFKGIDIESTSISLAANLGYTFDSGWRPFGIVGLGSLESSTNVLGHS
LSENNTSFHYGVGVEYAPKALSGLAFRVAYEGDMFIEENVYQDYGYYSYS
DDYAMNIGTFYAGATYKF
>VF0194 hypothetical protein
MLSVWFGKSINVKKKIVILAEYIGENHNSTAYYWSQITKHLQGEYEIVLI
APENKYSLFFASENKITTRFVKLAEHNKNNLLSRLQGQIKQTMSFLSVVK
EEVGSADLLFSGTNPIVTMASLVLLKWRYRFQWLVLVHDVFPNNLIPAKV
LSASSPFYKALIALSKKMYAAPDSMICIGRDMKVLLKQKIGNEKHIHYIP
NWASTEKIPSLNKSDNKIITDLGWQNQVVYQFFGNMGRLQGMGNLVKAIQ
QSTHQQARFLFIGCGSEADNVQKSLGQINEECGYDKTHFYGRLDLEKNHI
GLNACDISLVTLSDNMCGLGVPSKAYFSMAADKPILYVGDGDSELSILLS
EYPVGWACEPEQPTLLAQQLDAITENCLISEMPKMRPRVLLTEHFSEALA
LTKIARVVNSTIEL
>VF2326 N-acetylmuramoyl-L-alanine amidase
MLIGKYFRIIWYTLFVVLSTSSFFVSANTLEGIRVWPSPDETRIVIDLNS
EANYSYFTLSSPYRLVVDLKNTNVKAKLPLNVKDSKVLTKIRKSSPPSKN
TTRLVFELKHSVMAEVFKLAPTPGGQYGHRLVMDLPHSKTSSSTPAPSKP
SKPVINSSSNHIVGNGEIIIAIDAGHGGEDPGSIGPTRKYEKHATLAISK
KVVAQINAQPGMRAVMTRSGDYFVNLNKRTEIARKNKSHLLVSIHADSFR
SPQPRGGSVFVLNTRRANTEIGRWVEKHEKQSELLGGAGDVLAKNSNDRN
VSQTLLDLQFSHSQKEGYKLAKNVLSEMGKVIRLHKKEPVNASLAVLKSP
DIPSILIETGFISNPTEEKQLFQRAHQDKIARSISKAIIRYLHDNPPQGT
LLAAQGGQTKHKVRSGESLSLIAKKYGTTMAKIKSENNLKSTSLKIGQVL
VIPSNKSVYVAPKNTASSVNTSSSQARTIITHKVRSGEYLGKIASKYKVT
TSSIRSLNKLKSDTLFVGQKLKVSIVAPVKKHTVKRGEFLGKIASKYGVS
VSSLRKANKLRSDELAIGQVLIIPTS
>VF1889 outer membrane porin protein precursor
MENKFFKTTLLGAAVALASAGVTAKEVGINSDFNVEVYGVAAMSTVNYNT
TGNGDGTNGYVLENESRIGFRAHKEMFENVLVTMQIESGYVDSWQGGELG
ARDTYLGLSGDWGNLRAGRVLTPLYEIIDWPFSNPGLGSVFDWGGVNAHY
DRQSNQVRYDSPNFGGLTFALSAGRDGNPSGSATRDSRFFSGNVKYTIST
VTLMGAVEGGSDFRGVDDNDNLTYLVGAEVGLPGGFSLAGAYKQESVDKF
SGKNAAGVAVSGENVDQGSFSVIGQYWLDSLGFKVGYAANLDADGIKTVG
LKEESLDSNTISGQVMYVHNGFVPYLRVAGRTVGDKDTDIVTRVGLEYGF
>VF1399 glycosyltransferase involved in cell wall biogenesis
MNPLSIVIITLNEENRIGRLLEDLTEQTFKNFEVIVVDSNSSDATCEVAQ
SFSASIPDLTVHKMDKQGVSLGRNTGASLAKHERLLFLDADVRLSPDFLT
KALTQLNEKGLEVAGVYMGSKGLPVAHKLGYMTFNIGLFLTQFAFPTAVG
ACIFSTRRAHKDLLGFDENITLCEDCDYVKRASRTWRFRFLPMTFEFDPR
RLEQDGFLRMGYTYLKANVRRFLFGEMRNNEMEYKFGHYSNQK
>VF0350 putative capsule polysaccharide export protein precursor
MKPLFISFCLFLSFVSNALASEAQETPSDTQEKAKTEQSQQKEDLGYILG
AGDTIQISVFKEPEMTTRLKIHRGGYVNFPYLGEIKLSGRTPTQIEEDIE
ARLADGYILQPMVTVSIEAFRKFFISGEVANPNGYEFQPGLTVEQAIAMA
GGFTDRSDRDSINVRSAATNELIEDVAPTYPVGPGDVVIIEQSFF
>VF1329 soluble lytic murein transglycosylase
MRLMKKGFVGLILGCVSNSAFAISELWLDRYAYDAIQQGFNKKDISVYHK
KRGDLDNYPLSGYADYRAFLFDLENKTPEEVNQFSKKFADYPFSVSIRAD
YLNALIATKNWPYLIAYQTELPRDQDYQCWYYTAFYHENELDTAFDGAKL
LWLDGESVSSACNSLFSYWDKAGERTDNMILERALYAVDAKNPRLITYLR
KLASTVDSKDTLTEMLRLYRQPEKFTVVFETKEDTQFNRNYAQTALKHLA
KHNINSAYEKVDFVQSHFSFEVNELQATLEFLAVRLLDTKDPEIIQWRDD
VFERSNDSVVLEQRIRLAIRKTEWNEIIFWINKLTSEEQASYRWQYWLAR
SEMKLGDTESGETRLKRIAGNRHFYSIAASIALKREPRFPIARVECNKEQ
LEPYQDDIDRVEELLALGKTYPARKHWRHVVAKENQAKSAVLACYAKKKH
WHLFTHEATIRGELWDYIYLRFPVRYWKEFTRYGTKYNVDPVTLLALSRQ
ESGLELTTKSPVGARGLMQVLPSTAAFMAQKYNLNYRHSSDLFDLDKNVA
VGSRYLSHLLARYKNNRAYAFSAYNAGPTMVMVWRRAASKEIDIFGYIES
ISFKETRVYVKNIFMFEMYYREILKLEGDFLRPSELTNSI
>VF1161 periplasmic component of efflux system
MKLAINKYWIYLFLFSFVVVSVGYYFVRVDSQHKKLPFVVASIGSIEKKA
VAVGHIVPAHSISIKSQIDGIVGEIYHQVGEVVAINTPLIKIRPNPTPAK
LMLANTDLMQSEAKLELAQKKLENLKQLVEQNIIPENYGGYIEAKSDVKS
NKASVQQKKQNLDLILSGESSAGNSKLNSTIVAPINGTILNLKVEIGEPI
ISTASNQAATVMMSIADMSDIIFKGSVSEHDASRLTVGTPATVILASYPD
IVVSGKLRKVAVQSEKLNLTTTNTSTNSVKSFDNGFQVEVDQIQFPKNLT
IRSGFSATAQIILQQSTNVIIIPERSLQFKGGEAEVWVIDDSEYGYSSRV
VTLGLSDGVMVEVLSGLEEGEEIVDMSMMIGELNA
>VF0373 rod shape-determining protein MreC
MTPIFGRGPSLQFRLFIAVMVSASLMLADSRLNTFSDIRYLLNSFVSPIH
YAANLPRTMFNGMYERFNSRNTLMLENQRLKQEMFVQNSNLLLMEQLKQE
NSRLRNLLGSPFIRDEKKMVTEVMAVDSAPYTHQVMIDKGAADGVYEGQP
VISDKGIVGQINNVGAHNSRVLLLTDANNAIPVQAVRNDIRVIASGKGHL
DTMQLEHIPTNTDLKVGDLLVTSGLGLVYPEGYPVGYISKIDNDNKRPFA
SIDIETTVEFDKLRYLLLVWPTGKAPEEISDGE
>VF1106 hypothetical protein
MLLKLAWRNVWRNKMRTSIMLGAMIFGVVGVILMMGFMSGFIDNMVKNTI
QWQTSHIQIHQKNYALNPDINLVIDEEKEITPLLNDSSDVKAWSSRTLVN
GMIASARSTRGIKINGINLQMEKKITPLSAHIIDGEWLSETGRNPILVSQ
KTAERLKLRVGSKVVLTFSDTTGEVTGAAFRVSGIFKTSSSTFDDANTYV
RKADLQKVGKVFQDHEIAILLNDNTKVEAFRDHLITNINSDNSVQDWLQL
QPILSTMMSSMNAGNQVILVIFIVAMGFGIINILLMSVFERTREFGVLMA
VGMKKDRIRYLIILESGFLGLLGGGIGVLLSILCIAVFNHTGIPLESMAQ
GLNAFGIDSVLYPSISWHQYAVVSIMVFFVSVCAGLYPAHQIIKKNPVQA
MAEKQ
>VF0831 cell wall endopeptidase, family M23/M37
MKYKEVLAARINSLSKRHKLVLMSLSLFTVVVFIWEPTHSISQSLSEPSR
STVTLSSENLQTLADQNSEPVETIFDPNDPEFNAPKDELDKHINAEDIVH
SHTVDAGETLGAIFNQYALSISDMYALLDVNKSAANMRVGVDLEWQQDED
GKLTELKIHRNIKDTDVYAWNGEKYTFTQIEEKGEIKPVFLSGRVTSNFY
NSARSAGLTPGQIQTLAKQLQWKFDFGKEARKGDRFAVEIDKEFIDGKAV
SSGDVKAVLYKNAGRDITLIKHTDGHYYDVQGRSLNRALERFPTHQRYRI
SSPFNPYRKHPITGRISPHNGTDFATPVGTSVYATGDGVVVRALHHPLAG
NYIIIKHGREYMTRYLHLSKILVKKGQKVSMGDKIALSGNTGRSTGPHLH
YELIKNGRAVNAMKVPLPQASPVKSDERARFKQQAKLTIEALQEQV
>VF1582 periplasmic component of efflux system
MNKTKSIALVVLLACTLSTPSYAKKTRGNQSVAVLSEEVATHEISQSLSL
IGKLKASESVVISPEVAGKIERIAVKANQNVRKGQLVVQLNDDKAIAAIK
EARAYLNDEKRKLTEFQRLAKKNAITQTEIDGQKASVDIAQARLDAANAD
LSDLHISAPFAGTVGFIDFSRGKMVSAGTELLTLDNLSVMQLDLQVPERY
LSMLSVGMNVEATSQAWKNSVFSGKLIGVDSRINAETLNLRVRIEFPNKD
LKMKPGMLMAATLDFPAINAPIIPVQALEYSGTKRYVYVVGEDNKAIRTE
VTLGARVENRVVIASGLNVGDEIVVQGLVNMRDGVTVKQLEQNKTEVQ
>VF0302 alanine racemase
MSYMKAATAQIDMSALAHNLQKIKQQAPSSKLLAVVKANGYGHGLLNIAK
GAQGADAFGVARIEEALQLRAGGIVKPILLLEGFYSAGDLPILVTNNIQT
AIHCKEQLEALESTDLEFPVVAWLKVDSGMHRLGIRPEEFQEYVDRLHAC
KNVAKPLRYMSHFGCADELDSSTTTEQIDTFMSLTKGCQGERSLAASAGL
LAWPDSRLDWVRPGIIMYGVSPFAEQSAQELGYLPTMTLTSHLIAVRDVK
AGESVGYGAIWTSERDTKIGVIAIGYGDGYPRTAPNGTPVLVNGRKVPIA
GRVSMDMLTVDLGPDAQDKVGDEAILWGRDLPSEEVAEHIGTIAYELVTK
LTSRVQMQYT
>VF0963 peptidoglycan-associated lipoprotein
MQLNKLLKSLLIALPVVALSACSSSDSATDSTAGQESTNAAETQTTNGAE
GQTDTAVLSSIEADEAMNEAEVRAQAEQELRKVQTVYFAFDNSTISSEYE
DMLAAHAAFLSADPSIKVTVEGHADERGTPEYNIALGERRAKAVSKYLQA
LGVSADQISIVSYGEEKPLVLGQTAEDYAKNRRAVLVY
>VF0139 ADP-heptose--LPS heptosyltransferase II
MKILIIGPSWVGDMVMSQSLYITLKQQHPKAIIDVMAPAWCKPILDRMPE
VNQAIEMPLGHGDFNLLGRRALGKELKNNNYTHAYICPNSAKSALIPWFA
GVPVRTGWKGEMRYGLLNDLRPNKKAFQYMVERYVALAHPKSEMIDSSSL
GGLENLPRPALSIDAKVQKNTLEKFSLSLDKPILGLCPGAEFGPAKQWPV
EHYAAVANEMINRGHQVWLFGSAKDKETTESIKALVDADNQAAVFNLAGD
TSLIEAVDLLAACKTVVSNDSGLMHVAAAVGCHVVGVYGSTSPKYTPPLA
EKVDIVSTDIECRPCFKRDCPLGHLKCLKELKPILVLNKLL
>VF0345 lipopolysaccharideN-acetylglucosaminyltransferase
MKILLVNKFFFMKGGAETVYFQERDMLLSEGVKIVEFSMQHEKNIESEYS
EFFVQNVDYYQKQTIKDKLATAINFIHNRQACEKLQALLEQEKPDLVHFH
NIYHQLTPSIIKVAKQFGCKTVLTAHDTKIACPSYTMYRNGHTCEACVHG
SVWNATKYRCQEGSLSKSVLLSLEAIYQKISKNYQYLDAIVSPSRFLGRF
IQQKLPHNRIEVIVNGIDENVSLEGIKDNGYYLYLGRLSQEKGVPTLAEA
HQLMTEKAGLKIVGDGPEFNQLKENYPTAELLGFKSGEELLTLIKEAKAV
IVPSECYENCSMSVIEAMSYGKPVIGSKIGGIPEQIKDGIDGYLFEAGNA
QALADKLDLLVKEPVKTIDMGKNARERFLSKYTLTKHKNDLLNLYQELLK
G
>VF0961 TolA protein
MKADNNYTFAIGVSVVLHLLLVIALIFGSDFSLDDKAKPNTIQAVVIDPG
TIAKQANQIRQERERAERAEQERLKKLKQQAAQLEKNRKAEEERIRRLKE
KQVQEKKAARQAEEERKKAVAEAKKEKERAVAAEAERKRKADAAAKAEAA
KQAKIKADKEKAAKEAAKKAQLEKERAAKAEADRKAKEKAAKAEAERKAK
AEAERVAKAKAAEKARKEKAARAEAERKQKEAALNDIFAGLEDETVQNSS
AKQQHIDNEVNRHAAIYTQMIQQNLLVDETYVGKSCRVKIKLASSGLLLS
VTTLGGDAQVCRAAKTAVTKVNVFPMPKDADVVAKLTNINLTVQPE
>VF0470 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
MKIVLANPRGFCAGVDRAISIVERALELYEAPIYVRHEVVHNRFVVEGLK
QRGAIFVEELHEVPDDNIVIFSAHGVSQAVRKEAKERALTVFDATCPLVT
KVHMEVARASKKNIEVVLIGHAGHPEVEGTMGQYASDSAGMYLVETPDDV
IKLNVKDPSNLHYVSQTTLSVDETADVIDELRRVFPEIQGPRKDDICYAT
QNRQDAVRDMASQVDVMIVVGSKNSSNSNRLRELSEKLGTTSYLIDCPED
LKEEWLTEQTKVGVTAGASAPEELVNQIIEQVKAFGGTAVEELTGREENM
FFEVPKELQIKTVS
>VF0289 organic solvent tolerance protein
MSFTSRSLLASFTGCLLYGTPAIADNGSEPVSPENGIVFPLQTDAVNSCE
VPDKKSKEEEDQQPVLIQADSVEASNNSKAVYKGNVHIIKGRQEIKADSI
TLHQQENIAIAEGNVDYSSMEMRTTSDKVTTNLSTEDTTMVNTAYKMSCQ
PIRGQAGRVLKTGQEIYQLEDASFTTCPADDNSWRFKASDIELDQSDEWA
TFYNARFEVLDVPIFYLPYVTVPVGDTRKTGVLIPSIGLDSKNGFELSVP
IYWNIAPNYDATTTINYMERRGTQLETEFRYLTELGKGTVDAEYLNEDDK
FKDKGSRWGVSWDHSGIYQQHWKFDVEYSKVSDIDYFQDLNSSIGTRDEG
QLQQSGEVSYRSQDWDMTMRVRDFQVLVEEQTPYRLMPQIEFNYYAPQFY
SEFDFNLHSHISKFTTDDKAKPSATRVHLEPKLSLPLSGTWWSLIPETSL
LYTYYQQDFDKQPVGPNGSLNLDHEVSRTIPEVRINGAIYLDSTHKFLGE
YLQTLEPKIQYLYVPEVDQSNIYGGTGDGGYDSSKLQLDYYGLFRDRQYS
GVDYIADANQFSVGATSRFYDDAYKERMNISFGQILYLNGSGTEQNNDDK
NSSAWAMESDFNYDDYLFYHGGIQYDSNVSELQVANSTLEYRFSKGYIQA
NYRYVSKNYIESNVNFEDDLSLITQHGIYQAGLLSEYNLGRNWALKGQYF
HDTKEDQMIEALVGVTYLSDCWSFGLTYSDQLIAPESAKTIGTYEPEYES
NLMLSIAIRGLGNNTGITSGSANNALDYGRPFYLNN
>VF0196 undecaprenyl-phosphatebeta-N-acetyl-D-fucosaminephosphotransferase
MIRILDFLAAFFGLLFLWPVLLIVTIIGLFDTGSPVFIQERVGRNKKPFN
LIKFRTMSVETKSVASHLASNASITKLGAFLRKTKIDELPQLINVMKGEM
SLVGPRPNLFNQEELIKERDALGVYDVLPGVTGLAQVQNIDMSTPALLAK
TDRKMIDTLTVKSYFQYILMTATGSGSGDAVK
>VF2201 UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKNKNKRLLVMAGGTGGHVFPGLAVAKQLQSEGWEIRWLGTADRMEADLV
PKHGIEIDFIKVKGLRGQGLKKLIAAPFQILGAISQAKKHIKAWQPDVVL
GMGGYVSGPGGIAAWLSGIPVVLHEQNAVAGLTNQWLSKIAKRVFQAFPG
AFPNAEVVGNPVREDVCQLPHPKERFAQRTGPIRLLVMGGSQGARILNTT
LPEALPQLSHEIEIWHQAGKGSQETVEQAYRDNGIADAKVTEFIDNVAEA
YAWADLLVCRSGALTVSEVSAAGVGSIFIPFMHKDRQQALNADHLVQCGA
AQMIEQQDLTVQGLVDTLNGLERKQLLEMACNARDAAIIDADVRVANAIK
SLAK
>VF0182 glucose-1-phosphate cytidylyltransferase
MKAVILAGGLGTRLSEETSVKPKPMVEIGGKPILWHIMKLYSAHGINDFI
ICCGYKGYVIKEYFANYFLHMSDVTFDMKENKMEVHHKRAEPWTVTLVDT
GDNSMTGGRLGRVADYLKDEEAFCFTYGDGVSDVDITKTLEFHKAHGKKA
TLTATFPPGRFGALDISAGKVNSFKEKPRGDGAMINGGFFILSPKVLKLI
DGDSCTWEQYPLNKLAEDGELMAYEHHGFWQPMDTLRDKVYLDELWQEGK
APWKIWE
>VF1917 lipoprotein-34 precursor
MKVKTRFVVGSLMIAVLSACSSSPTERRQAKQDFKYLETPPLVEWQEPAD
AKPEFYPQYDIPKGEFTGGIGKEVDIRPPQQVLELIPGARIEEQNGEVTV
WLVKQEDVDKLWQTVLTLMKKKDIGIVKEEPSEIETDWLKWSSEDEDHEF
GARYKISKLNQNNRVGFQILLIDWQVDGNQAEVTPANKARYNILMTNLVT
SAYDEQLREEARIRAEELVKRIPISMGQDRSGLPVIIARAPYNIFWERLG
ELLPMMGLAIEDRNRSQGTIEVKYKEPDDEFWEEIGTKPLSFDGRTYNLL
LGDLGNRTSINVTDAGGKPVDEDTLDSLVPVLAAMIEKSNNAPKTEQDEE
>VF1952 UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase
MSRITLAELAEKLDATVHGDGTVVVHSIASMSKAKEGDITFLSDAKYRKH
LVECQASAVIVKEADVEFCQSNVLIMRDPYLGFALAAQALDTTPAPASDI
APSAYIADDAIIGEGVAIGHNAVIESKAVIADGAMIGAGCFIGKEAKIGK
NTKLWANVSVYHRVEIGEACLVQSGTVIGSDGFGYANDRGTWVKIPQLGS
VIIGDNVEIGANTTIDRGAIDDTVIESNVIIDNQIQIAHNVQIGSGSAMA
GGTIVAGSTKIGKHCIIGGGSVINGHIEITDGVTITGMGMVMRAIDEKGM
YSSGIPLQTNKEWRKTAARVHKIDEMNKRLKAVEKKLVD
>VF2574 methyltransferase GidB
MTDLSQQFDRLIAQTDLNVSELQKEQLLGYVALLHKWNKAYNLTSVRNPS
EMVIKHILDSIVVSPKLSGERFIDVGTGPGLPGIPLAIMNPEKSFTLLDS
LGKRIRFIKQVIHELKITNVTPIQSRVEEFQPEEKFDAVLSRAFASMTDM
VNWCHHLPKEEDGVFLALKGIYSEEEANDLPEWCSVKNVATLIVPELEGE
RHLVTLAGKK
>VF0147 acylneuraminate cytidylyltransferase
MKNFAFIFARGGSKGLPGKNIKPLAGKPLLQYSVDTAIASPSIDKVFVST
DDSDIAKVAVESGAILIERPAELATDISPEWLSWRHAIEWAEEYHGQFDG
FVSLPATSPLRGVEDVEAAIEKRSKVGADICISITPASRSPFFNMVKETQ
DGLVELVNKPESNVTRRQDAPEVFDITTVVYVTTPDFVLNNYGLFTGKVT
SIEVPKVRAVDIDDIYDFRMAEAILQDAK
>VF1702 membrane-bound lytic murein transglycosylase B
MKKKLLLGIVSLFLATSASASATPEGDFQDYIVGLKNEAREIGISEPILE
RAFKNVAFKEKAVKSDRNQPEKKLTLDEYIPRAVPKWKIKQANDLYKKHY
KVLNRIGEEYGVQPRFIVALWGVESNFGKLTGGYNVIEALTTLAYDGRRE
AFFKKQTMAALTILQQGHITPENMKGSWAGAMGQCQFMPTSFLSYAVDGN
GDGKKDIWNTHADVFASAANYLKQVGWDDTYTWGRQVQLPESLDAESLKG
LSEEKGKTLAQWQELGVRRLTGKALPDADIKAWLVQPDDKDGRAYLVYNN
YQVLMDWNRSHYFALAVSHLADSIK
>VF0297 acriflavin resistance periplasmic protein
MKINKKYLFFPVVAVGVIVLITITKLRPDAETKPLEDRSKVVNIQLLEPQ
SIAPQAIGYGKIRPKFEWKAIAEVSGKVVYRHPELHKGNILLAGTEVLRI
DPLDYELKLAQAEADLGSSQTQLAKVDLEEKNIRNTLKIEKNRLSISKKE
LSRKINLQKKGLTSQSDLDQQNQSYLAQQKVVQDIQNQILLLPDEKKVAA
AMVKVNQAKLEEAQRSLEKTSIILPTDVRISEVDIEADQVVNLQQTMFIA
HGIKTMEMEAQISIHDMQTLAQSVKAFQLSEQGMPNIDSLPLTANVELSS
GRFDAKWEAKVARISETVDPNQATVGVILEIDQNYRALQPNSLPPLVNGM
FVKARIEGDASEQWVIPESALHGDKIYLLGQDNKLIILPIEIVYRRNNQV
AVAGDIKSHDRLILNDLLPAINGMQLRLAKSHNDEEPVQ
>VF2198 cell division protein FtsQ
MALTERLSWQVVLDNGIRLELGRDSREERVERFIALYKQLESKKDSIDYI
DLRYDTGAAVGWKSDDVENKEEN
>VF0555 TagE-like gene
MPDKIRISVSHNKGTRLFAISQRRKKLVILSLVLGVSSFALSGFGLHYFY
QQQESAKVAIAELQNKNNVLNQLIVDNNNSNHELTQQLEAKENELLVISQ
RVDDVESVLGLQEISEEDSSLAEKTLEQRLDVAAIDSAVRATMFRLIPND
TPLHYTRESSSFGRRTNPISGKRQRHLGVDLTCKRGTEIYAPADGVVELA
RASNKGYGNLLKVQHSFGFMTMYAHLQKFKVRSGQFVKKGELIATCGNSG
NSTGPHLHYEVRFLGRVLNPRSFMDWTPEKFDSLFEKERSVKWTPLVDVI
NNVVKLQLKLTQKPTVEQVEAINTAKAENESSQQLTQ
>VF2209 S-adenosyl-methyltransferase MraW
MSEQFQHVSVLLHESIDGLAIKPDGIYIDGTFGRGGHSRQILSQLGENGR
LYSIDRDPQAIAEAKTITDPKFTIIHGPFSGLKQYVEELDLVGKIDGVLL
DLGVSSPQLDDAERGFSFMKDGPLDMRMDPTSGIPVSQWLQEADVEDITW
VIREFGEDKHAWRIAKGIVAYLENEENEPLTRTSQLAKLISEVAPKSFKE
KKHPATRAFQAFRIYINSELDEIDTALKGALDVLAPEGRLSVISFHSLED
RMVKHFIRKESKGPQVPHGLPLTEEQIKALGSAKMKPVGKAIKPTKNEVN
ENVRSRSSVLRIAERL
>VF1978 accessory colonization factor AcfA-like protein
MKKYLFLLMAATSTATIAAPYVGLEYGLTNMSHDYSTTFSNDNVSLTPDD
SSSAFGGFVGYRFNEFGLEFGYKKFESDDSRSQMLVSDKPGYTKEREWDA
DLDATQFTFKPVYFYNINEKVQLKTGLGLTYTQYKFDSSANTEYENDLTD
HEFTQDYVAGDSKSESVFGGIASVGIEYMVIPNLALGASASYQVDSIANS
TSFMLSSAYYF
>VF1506 iron-regulated protein FrpC
MKETLIPSKVEIKNIEGDAYTLNKSGVPTKVNVGQSMNADDILFTGYDAK
VVVQIHGKLVTIDKNCISCLDETKSEELLQVKNIEGDIELDPTQSIDEND
IAAIQDAILAGEDPTEILEATAAGESGSSANSGFVTINYAYTASIATTSF
TTSNEFSYDNQDYIDSLGDGNGSNPPADPIITANNTGLTKEDEIINTDGQ
LAVTNPQSNLSYTWSINGNATSEYGTLSLNAVTGEWEYILNNSALSVQSL
ANGQIITDVFEVSVSAGGNLTSTQEVTVTIIGTNDDPVISGIAVGDLTEG
DVGDPNPTVSDTLTVVDVDATDTHTWTILEGGSGVYGVLTINNGVWEYTL
DNSRDATQALGQGDVVTETFTIEVDDGNGGTDQQEIVITINGTNDEPVIS
GTNSGRVVEDLIDSAEGQLIAVDADAGDSVTWSVTDPSLGMFGSLTIDAS
GKWVYSIDNNLSATQALSNGEVQTETFEVVADDGNGGTVTHTVTVEVTGT
NDLPEITDTSVTTGAVEHRTTESATGDLIFEDVDALDTHTWTVEANSNDD
LGTFSVDANGKWTFNLNTNSASVIALGVGETLEITYVVQVEDNHGGIDSQ
EVTITVTGSNDGPVISGTDTGAVVEDTVAEASGQLEATDADVNDTATWSV
TDDAGVYGSLTVDSTGKWTYVLDNTLTDTQAISNGEVKTETFEIVVDDGN
GGTVTHTVTVEVTGINDLPEITDTSVTTGAVEHRTTESATGDLILEDVDA
LDTHTWTVEANSNDDLGTFSVDADGKWTFNLNTNSASVIALGVGETLDIT
YVVQVEDNHGGIDSQEVTITVTGSNDGPVISGTDTGAVVEDTVAEASGQL
EATDADVNDTATWSVTDGAGVYGSLTVDSTGKWTYVLDNTLTDTQAISNG
EVKTETFEIVVDDGNGGTVTHTVTVEVTGTNDFPEITDTSVIAGAVTEET
TLTTSGDLFVDDVDTLDSHTWTLLSSNNDPYGSITVSTNPDGSGKWEYTL
NNTAAQVQALANGETYTVEYQVQVDDGQGGVTTETISIEITGTNDDPIVS
GQSTGLVKEDTATQSEVEGQLTVDDVDLIDVHSWSVDSNAGTYGSIVIDP
ATGLWTYSIDNSLPATQALTEGESVEDKFTVTVDDGQGGTDTIEIIITVV
GTNGVPIIGGDTVGEVTEDTTLTATGTLTATDEDATSSFNWNIVGSDTGT
YGKFTLDASTGVWLYTLDNDAAQSLGAGDDPIKEYYTVELSDGAGGVITE
TVEITINGTNDKPELSGQTLGSVKEDSIETTEGQLIVDDVDLTDTHTWSV
EPATGKYGSIVVDANGKWTYTIDNSLDVTQQLAEGESGEDRFVVTVDDGQ
GGTEQKEIVISLEGTNDLPSIVDSNDTGTVTEDGVQSISDTLTVEDVDLA
DTHNWFVIGASESKLGHFSIDAATGEWTFVLKNDEAQLLAKDETVVESFV
VVVGDGNNGYAQHTVEVTIVGTNDRPEITGRTTGTAVEDIIPTATGALTA
VDVDFTDTHTWLVDGGGVGKYGTMTIDVNGNWIYTLDPSNPDTQALAENQ
QEFETFTIAVDDGNGGQNAIVITVEILGTNDVPIIGGKTSQTIIEDDKAS
VSGQLTDGDVDLTDTHTWTLLTDPQGIYGSMSLDANGKWTYTIDNSSPLT
QGLLEGQTVKEKFIIQVEDQYGAIDTVEVTVKVKGTNDVPELSGDLSGVV
EEDSAITMVNGKLEPDDKDIGDTYTWTLDSKTGSYGTLTLTADGRWVYNL
DNDKASVQSLSEGERVQDTFTVTVTDGFGASTSKEIVIDIVGDNDQPSIS
GATTGSTIEGTPGKDVATGELAAVDIDTLDTHTWSVVTPNGVYGSLVVDP
NTGMWTYQLDNSRPATIGISSGQIVQDKFVVQVDDGQGGTSQIEVVIDIA
GTNSSPGIIGDTTGEIKEDAAVNVIDGDLNSGDLDTQDTLTWEIVGSTGQ
YGQFTLDQNGHWTYTLDNSNSTVNGLKEGAELVDTITVKVTDSFGEVSEK
EVEITIEGTNDAPTMTGALTGTVIEDTTTVIEGQLKSGDPDVGDVHAWNL
VDGVGQYGALTMNANGRWTYSLMNSLAAVQALGPSDILTEIFTVIVTDSQ
GESVQKDITITIEGTNDLPEITGGTTGEYIEDVSPDVVTGQLIATDVDAG
DTTTFEMRTYVGNYGTFYLEADGSWRYEINKDSAAIQSLNEGEMISETFT
AVVHDSNGGFTNEQIDFTITGTNDRPVVSGDNAATVIEDAQDFLPPGETF
NGQFTKVTGNVIADDIDLGDEVVSWQVINGSGVYGIFTVDENGQWTYLLD
NTDPDTNALNFGDVRTEVFQITATDKHGGISEPFEVTITVEGNTDPDGGG
GGSYDEVIDIDSIEEGVDGDGNAIGGGSSGTIDLPSGCEIISVDGTSSID
GGLFGSLTVDNDGNWVYDVADDKSYVDSLCEGQEVTERWAVTVQTDCGTE
TILVNVTITGSNDVPVIIADTDTGELGEVVEDDILEVSGQLEVVDPDSCD
THTWYLVDVDGNKIGTLDPSGENIVIQGVYGELTLNQSTGEWTYVLDNDS
EIVQALTPDQIEKEYVRVVVEDDKGAVSSDSTININIIGVADDAPAVAVI
EEIEFKEDGSPLTQTGVLDDVAGLTPELTWNLVTGDGTYGHLTLDNNGNW
TYVLDNDSLAVQQLNEGELVTDTFSVTVVDKFGKTVVDENGDPLEMIFKV
DVTGTNDAPEISGQLTGTISNIDSDGRISGNLNDGDVDTGDTHTWSVADN
QGDYGRLMLVNGKWTYTLDTSLDAVKLLGVGETLSDTFEVTVTDSYGETS
TETITVTIDGSNLPPEIAQDDQIVMELKEDEKITDSNTLVVTDPNGDDVT
FDAKTLTGTYGVFTVDENGVWTYELDNDAAHIQGLREGEVVSETFTVFAV
DEHGAKTAQEVTINITGTNDVPKISGMDTASVEEADGSTASGNFVTSDVD
VGDNVVVSPGTQGSYGSVSVDNNTGRWTYTVDGNDPAVNSLSKGETLTDT
ITIIATDDAGDTAEMTITITINGENDAPDLVVTVPSEVTEDTDLNADGNL
EVTGNWDDGDPDTADTHIWEVLSGDSLGTLTFDPNGDYKLVIDNSALEIQ
QLGVGESLDLTYTVKVTDEHGLSSTQDITFTVNGTNDDPEVVDTSILSVD
VEEDGIGTQTQSGQLDITDIDLNDTTFDFSVTTSPTDAYGSVTVDANGKW
TYVLNNDKAQEIGDETITETFTIQIDDGNGGVITQDVTVNITGTDDDPII
DTTIPQVTEGTVVEDGTLTATGQVSYVDPEGDVINYNVINPPSSPYGTFT
VGADGTWTYELDNALAQEIGVAGAQETYTIEVTDQTGGTIQQVITINITG
ANDDPTIDVSSVIIGSVEEDGTATAIGQLDVSDVDLTDTSFTYTVVSGPN
TAATPGDVTGLYGALTVDANGEWTYLLDNDKAQALGDTVATEIFTIEVSD
GNGGTVTQDITVSVTGHDDQPIVDAGATQETTGAVVEDGELHAEGTITYL
DPEGTLIGYTVSTTSTPLYGTFIVDPATGKWEYDLIDSLAQAIGADGAQE
SLVIDVTDATGQVTQQVITIDITGENDAPVITGTTTADVKEGVVETVSGQ
LNATDAESDPIGWQISSSSSATGVYGTLSINAAGLWTYVLTENSTLALAT
DTTDVFTVEASDGKGGITQQVITVAVAAPNVVQGVSGSDILTGTTNDELL
FGNPLDLSDAGTADTFTWTNASIGGDLARDIIKDFDVNSDRIDLTDIANI
TTVWDSATLASQIQISEVDGSTEIYINEAGSTVQTIVVDGVTLDELTGES
TASMTDEEKLTSLTNSGHLVVSDTFGNEANNTLYASGQNDILTGGGGNDI
FYFADEIAGSSASPAQTSIADFAVDGVAANNEADILDLAELLPDSIQASS
TMDDMLQHINVNIDDSNSQTVLSVTDELGNQTDITLKGVDSTTLGISDLG
SMSDQDILSTLYNDFNMFKVD
>VF1799 lipid A biosynthesis (KDO) 2-(lauroyl)-lipid IVA acyltransferase
MTEKIDKNVYNPTFQWAFLHPKYWPTWLGIGFAIILAFIPFRLRDKLAAK
IVKLVLKKPSGGIKRAKLNIATCFPEKSEQEQQKLLEDTYITGAQVMLGF
SELLVRSRKHNEKRGIFVGGENLFPLLEQKENIIILAPHAWAIDFPAILL
ASRGYHVTTMMKPQKNPITDWLMHVQRMQYGGKIYARSAGIKPLIKAIKE
GYLAYYLPDEDHGPQNSVFVPFFATQKATLKGFGKLARLSKAKVVPMLPS
YNSETGQFEIITLPAIADFPSGDEETDARAMNIAIEQLVTERPEQYMWVL
NLLRSRPGGSRLY
>VF1368 membrane-bound lytic murein transglycosylase C precursor
MKNVLIPFIISLATVSCTPIFDGNFQRPNSNSCNCESDITNSNNNTTSKP
DSWKPSTSKPNQSIEEQLENLANHVHKTWGDKEFLEAGKHRYVKYLDGYR
TRAHIDFDKGKIYVSTISQYQPKETLKKAIIGTVLMPADPSHVDLFSDKS
IPLRGRPFLLGQIKDQENKDIEWPWRAGRYADYLIENKLQTKTIKNGKAY
YVEISMVDDHLEQREFQYADLIKKASKEYDISIDLIYAIIQTESSFNPYA
VSHAGAYGLMQVIPKTAGADVFKLVKNKPGIPTKEYLFNPAHNIDTGTAY
FYILKNRYLRDIKHPTNKHYSMISAYNGGSGGVFSTFDPSRTKAIDEINS
LQPNQLYWALTNKHPKAEARRYLEKVLKFQKEFNEKS
>VF0340 probable transcriptional regulator SyrB
MATLLTQGTLLEAKKIKKPLTKSFLLSLTILFFFCAHFFQPNPGGSGLHL
AFNAASWIPASIAIAIALFHIAKQGILKFSTLSIVLFISVCLLSIPLLYQ
EASPHLATGKFLGLWAGLLFFITLQQFSFSNKQKQWLLWCIIGSVLIETL
FGYIQYLFLETGNSFGYNVIVNRPYGIFQQPNVMASFLVTGLAIASYFLA
RQPIKYRENIIALTLLYATIIFTLPLIVVLASRTGWLSATFSLVLLVPYM
WKYCTKPRFISWLLALVVGFSGSFALLDLSKNDDISNVTLISKKADLESA
REYIFPQALDMFLEKPVTGYGYGNFEAEYILYTAKQHQLSSDYRAGEPSM
DHPHNEILYWGVEGGIVAILGLLLAAGGVLAKIRRSKLDTQFALLALIAP
IFIHSQLEYPFYHSMIHWFTFIILLFWIDQLSCKYKKYRISDISKITLRV
SSLVLPIVTGFYMLSTLHTNWVLTQFETTKPMNPDILSRVTNPVVWEDRF
NWDVLSTQLKIGIINKKPELIKPYIEWSQELIKTKPRPAFYQNLIIAYQA
LGDEKRAEDIRREAIFLFPKSKFESVQLDKKLQMTN
>VF1225 TonB protein
METFVLNFRYLAAAGISLAIHTALIWSVPEKKAFAMPTGSTSSQVNIQFV
APSVPTPQSVQTKKNEVTKPKEQPKQQTTVEKTVQKQVVKKKPVQSKQKP
KPKKKMVKKPTISKPIEPEKKILKEKAETKPTTKTAKKTDKPVEKESTAK
PVASKSGATEKPQLVQKPNFLKRPNAPRYPRIAQRKGIEGTALYEIWLNE
NGKQIKQELITSSGAQVLDEAALNAIRDWQFSPQVINGQAIAHRVQIPVR
FSLN
>VF1795 Outer membrane protein C
MKKTLLALAVPALLMAGSASAATVYTAEDGSTIDVYSRLGFNITDRNDDG
DSVGNFDARIGLGGSQVVNDKVSVIGWAEYQVNAAEARGNGDWSPRYVWA
GIDASEAGKVTFGRVASGIIMLSDIGDVFAASDVVLGRQLQLVDNSSAQT
FRQDGTIQYQNSFGAFDMSVAYILGNTDSDQDGSYNAVGRYTFDLGDAGT
LAPVLAYQANSTGDNAINPDADYTFWGAGLQYKLNALTLGAMYNQDEIEG
VYSDKSTDKSYELTAVYNINDDWTARVGYRSLENSGGDEAEYKDTTFEVQ
YHLTERSSIYTSYVMRDGDNGNVTTAGPVMTDWNNAEEDYYHLGLRYEF
>VF2204 phospho-N-acetylmuramoyl-pentapeptide-transferase
MIIWLSNFLEQYFPFFRLFEYLSFRAILSIITALTISLWMGPKLIAWLQN
LQIGQVVRDDGPESHFSKRGTPTMGGIMILTAITVTVFLWADLTNPYVWA
VMFVLLGYGAVGFVDDYRKVVRKNTDGLIARWKYFWQSSIALVVAFALYA
YGKDTAATQLVVPFFKEVMPQLGLAYILLTYFVIVGTSNAVNLTDGLDGL
AIMPTVFVAAGFAFIAWATGNVQFANYLHIPHIPLASELVVVCAAIVGAG
FGFLWFNTYPAQVFMGDVGSLALGGALGTIAVLVRQEFLLVIMGGVFVVE
TLSVILQVGSYKLRGQRIFRMAPIHHHYELKGWPEPRVIVRFWIISMLLV
LIALATLKVR
>VF2195 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
MIRQRTLKSIVQMTGVGLHSGRKVTLTLRPAAANTGVIYRRTDLNPPVDF
PADPESVRDTMLCTALVNDEGVRISTVEHLNAALAGMGIDNVVIEVDAPE
IPIMDGSASPFVYLLQSAGIEELNTAKKFIRIKKPVRIEDGDKWAEIRPY
NGFRLDFTIDFNHPAIESDDQKLVFDFSSQSFIKDISRARTFGFMRDIEY
LQSQNLCLGGSFDCAIVLDDYRILNEDGLRFDNEFVTHKVLDAVGDLYMS
GHSILGELRAYKSGHALNNQLLRAVLADQEAWEWTTIEDEQESPVAFMQP
GMVLA
>VF1955 membrane metalloprotease
MSELLWNLASFIIALGILVAVHEFGHFWVARRCGVIVEKFSIGFGKSLWS
KKGKDGTEYNISMIPLGGYVKMLDERVDDVPEEQKERAFNNRPLWQRSAI
VAAGPIANFLFAVFACWLAFMIGVTALKPVVGQVEDGSIFSKAGITAGVE
LKAISGIQTSDWEAVSMAIVSHIGDDSMTVTYSDENNIGVEVTKRLDLSQ
WNFDPEKDSPLLSLGFLPYRPALTLDVANVSSNSAAEKSGLLVGDRLVSV
NGNALTKWQEMVDVIQGNPSKAVDLVISREGQTVDLVLIPDSKEIADGKV
IGFAGVSPVYQEWPEGYRYEKQYGPIVAFEKALAKTGDIIDLTLTMTKKL
FTGDVALNNLSGPISIAKGAGTTAEYGLVSFLGFLALISVNLGIINLLPL
PVLDGGHLLFFAIEGITRKPVSERVQEIGYKVGTAMIMSLMAIALFNDFM
RL
>VF0755 apolipoprotein N-acyltransferase
MPLLSHYFIRLLVALLSGASATLAFAPYSLWAFAFIAPLILLLLMHKQTT
KKATWLGFVWGLGYFGAGVSWVHVSIDNFGGMPVAASLFLMIGLISYLSL
YPMLFAFLLQRFFSNHNITKYLLAAPALWIITDWLRGWVFTGFPWLWLGY
SQIDSPLSAWGPILGVEGITVMILLSVGTMAYSFIDKKWGLLLIPAVIFA
TSFAIKPFDWVTPQPDKATKVALIQGNVNQAIKWLPSERWPTIMKYMDLT
RKNWDADVIVWPEAAIPALEIEIPSFLRNLDSAATMNNSTVITGIVGQSP
TGNFYNNIISLGVNGTNGYDYGQQPRYSKHHLLPFGEFVPFENLLRPIAP
IFNLPMSSFSRGDYIQPNMEASGSHLAPALCYEIVYGEQVRENITSQTDY
ILTLSNDAWFGTSIGPLQHMEMAQMRALEIGKPVIRSTNNGVTAITDHKG
QITKQIPQFTTAVLRGEVIPTTGTTPYRYWGSIPLYLLVGLFLLVAWRKR
KDNM
>VF1455 mechanosensitive ion channel
MRHFIWILLFFSSLSFASEAQDLSHLEKINAEIARLKTESNSFSGSELAI
IRVQQVEKNNELRSVLSQLIQEHDKTTKELLISEVNNQIGYAERSFAYLD
KELKSKQAQLDKADIEHKLALQNTLKETRDYYYLSLSDQLENYQWLADLG
ESNEAQIDAFKLLIDQKIKFLSASLSFDASREQRLSDQLQHSSESEKSSL
TLDHLFFERKVFNSTSGLEKLISIADQLDINTTDYKRQLFSTTGNLTEDI
LKFPVIAAILSNWISSGSNWLLKHAPDQLLKFLVFILILFATRLIARLTS
RVVLKAVVQPHLRMSKLMQDFFVSMSSKLIYFIGILIAFSKIGLDLAPVL
TGFGVAGIIIGFALQDTLSNFASGMMLLIYRPFDVGDLVEAGSVSGKVSH
MSLVNTTIKTFDNQIIILPNSMIWGDVIKNVTHERVRRVDMVFGIGYEDS
IEHAEKILAEIVDAHPAALKKPEPNIRVHTLGASSVDFIVRPWVKTDDYW
DVYWDITREVKLRFDKEGISIPFAQQDVHVHFAKKDKKPKKPNPITEKIG
NVIDSVRSKDS
>VF0766 outer-membrane lipoprotein LolB
MRLSRMFPRFVRSPFTILIFTLFLNACSTTPLTPQQSTDWDKHQAKLEQI
TQYKVTGKIGYQAPNQRHSLNFQWIQKPEQSQLLLTSFLGQTVMKLTMTE
QMTTIETGDGQKFEGRDPGKLMYSLSGISMPIGYLQDWIKGLPTAADNFQ
LNELNTVEHLSKQIGQTNWHLRYNSYIEKSNLLLPNSMKLTQQDTTIKII
ASNWIISQ
>VF0198 UDP-glucose 6-dehydrogenase
MKIAIAGTGYVGLSNAVLLAQHNEVIAVDIMAEKVELINNKKSPISDVEI
EDFLVNKKLNLTATLDKEFAYKEAEYVVIATPTDYDPVTNYFNTGSVEAV
IKEVMVINPKAVMVIKSTVPVGYTERIKQELNCENIIFSPEFLREGRALF
>VF0151 O-antigen ligase
MINNYCQKILSSISKYWVLAIVYIPILWTLSFNFTLPNGRSIASKLLVIS
AIFSFIYFRKRVFLFKEKPKTFKILITSLFIIILFRSILFLYHGEQTSSI
RAFGIIFLYIYSFPYWLVKKEHIKNLTFISLFLFGLDAFIHVINNGFTRY
GGNTNPNPYGLYAALIFIFVYIYNLINTKTHILYKTIPLIIIGFLPIMIS
QSRGVWVSTILTLIIIHIARIKFNIKNISIYILTILAIAFSLYSTPTVKN
RIEATKIEIKNIEHHNLSSSLGVRIQVWKDSIPLIKEYPFFGLGNKLKEI
NNTRFENKKISQYSYYYSRNHLHSQYFEFITKQGFIGFFIIIGAIIFPLI
IMRKDNDIFVKFCSISFLCVLLINFITEVPFNWINFTYTYLILILCLTLQ
SYHSTKDIRS
>VF2089 GTP-binding protein LepA
MKHIRNFSIIAHIDHGKSTLSDRLIQVCGGLSDREMAAQVLDSMDLERER
GITIKAQSVTLDYTAKDGETYQLNFIDTPGHVDFSYEVSRSLAACEGALL
VVDAGQGVEAQTLANCYTAIEMDLEVVPILNKIDLPAADPDRVAEEIEEI
VGIDATDATRCSAKTGLGVDEVLETIVKSIPAPEGDPEAPTQALIIDSWF
DNYLGVVSLVRIKNGSLKKNDKIKVMSTGQVWGIDRIGIFTPKQIDTDVL
NTGEVGWVVCGIKDILGAPVGDTLTHAKGGCEERLPGFQKVKPQVYAGLF
PVSSDDYENFRDALGKLSLNDASLFYEPESSAALGFGFRCGFLGMLHMEI
IQERLEREYDLDLITTAPTVVYEVAKTDGEILYVDSPAKLPAVNDIDEIR
EPIARCNILVPSDYLGNVITLCVEKRGVQVDMQYHGNQVAVTYDVPMAEV
VLDFFDRLKSTSRGYASLDYNFQRYEASSMVRVDVLLNGDKVDALAIITH
KDNSQSRGRLLVEKMKEFIPRQMFDIAIQAAIGNHIIARSTVKQLRKNVI
AKCYGGDVSRKKKLLKKQKEGKKRMKQIGNVELPQEAFLAILHVGKD
>VF0475 OmpU, outer membrane protein
MMNKKVLALAVAAITSAGAVNAAELYKDEAQSIEMGGRAEARLAMKDGDA
ADNTRIRLNFKGTTQISDGLYGVGFWEGEFTTNDAVNPNGNLENRYTYAG
IGGNFGEVTYGKNDGALGVITDFTDIMAYHGNSAAYKLAVADREDNAIAY
KGQFGDFAFKANYRFDDAAANQESNDGFSTSGIYAFGDSGFKLGAGYADQ
GTDNEAMVAGSMTMGDFYFAGTFTTGEVVDLDYTGFEVAGAYTMGKTVFT
ATYNNADHDTNALTVANNENADNFAVDATYFFNANFRTYISYNLNLLDDD
ASKGITKAMTEDEVALGMRYDF
>VF0201 UDP-glucose 4-epimerase
MNILVTGGMGYIGSHTCVQMIEAGLTPIILDNRYNSKEVVLDRIEALVGV
KPKFYQGDIRDPKILETIFAENQIDSVIHFAGLKAVGESVEKPIMYYDNN
VSGTLVLVEAMRKAGVNSIVFSSSATVYGDPASTPIREDFPTSATNPYGR
SKLMVEECLTDIQKAHPEMSVTLLRYFNPVGSHKSGTMGEDPQGIPNNLM
PFISQVAVGRREFLSVFGNDYPTVDGTGVRDYIHVVDLADGHLAALKYKG
QEAGLHIYNLGTGNGNSVLQMVTAFEKASGAKVPYKIVDRRPGDIAECWA
DPAKAREELKWEAKLSLDDMTADTWRWQSNNPEGY
>VF2205 UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate--D-alanyl-D-alanyl ligase
MITMLLSEIAKACDGRLVGADCQISSVSTDSRHIDEEGLFVALIGERFDA
HDFIPAVQEQGATALLVSKEVDTTLPQVIVSDTQKALGLVAKHVHQVCHT
FTFALTGSCGKTTVKEMLASILTRSGEVLATAGNFNNEIGVPLTLLRSQP
SNDFAVIELGANHQNEISYTTQLAQPNVALVNNIAAAHLEGFGSIEGVAK
AKGEIFEGLQENGIAIYNLDSNGLPKWSSLFEGKQVVSFAMDDSSADFYA
SNIEVNAIGEPSFQLNTPKGNIQVSLGIIGKHNVANAVAAAALAIQAHAS
LNDIQQGLQELGSVKGRVAVETLASGLKVIDDTYNASVPAMKAAVDLLGG
FKGQRWLVLGNMAELGEESLALHREVGEYAAPYQFEQVVTFGDDTKVISE
LCNGRHFETRSDLNAYLLKELQLIKHNEVTVLVKGANSSRMSEVVSALKE
CQ
>VF0349 chain length regulator
MALSIIENGKKLESTIDFSNFLKEFKKYRLRVLLVVLAITLAAFPLINGM
TPQYTATATIVLKAKTDNSTPIDQVEDFDATQAEYYPTQAELLQSKTVIE
AAAKKLDLINSPIFEDEDKDENIPQSEEEHLYSIVKAIKKKLSISPVRFS
QLVHVSYESKDSDMSALVANAVVESYIEQQEQRKIEKTQQAQQWNNTRMS
ELKEKIKQQKADIDKFLSDNGLLTYQGVDGFETEQLALVNDRLATAKEKR
ITAKANYNTISEALGYPLEDVATLPSISNHAQLQDLRIALIQAKRTLFDL
QKMYGPKNRQILEANAQIKAIELQTTALLKELKTGLYKEYQAAIERENKY
RALLAEQKKDFTALAAKKDTYNTMKADLDKTQELYEKIFLRSKEQELTVL
YREPVARLLDAATPPHKPSKPNKALLLIMVCAMTIIFSLLFIIIKSALNK
SINNLTQVNTRLGLQGIGELISLNYIDELALFTKNFFKNSYSAETVHAIR
TTILLDDKPWPIIGLTSTESTESNELNSYLLAYSFSQDRSTLLIDLDYRK
EISLTEAILMQKENEIDAKKAENSDDFETVPTSTVMGVAEALEQKHPIND
CLIKIENNLTFLPRGTLTETPLITLASEELGRQLKELSKQFEQVIVNLPA
MTESKDAQLIARHLSGVIYTVQAGELSANHILANIEKVKQVQTPIMGVIL
TDVQNDELETEEAKQQLIHQNDDILG
>VF0401 UDP-N-acetylglucosamine1-carboxyvinyltransferase
MYKFRIQGSDKPLSGEVTISGAKNAALPILFASLLAEEPVEVANVPKLRD
VDTTMELLKRLGAEVSRNGSVHIDASGVNDFCAPYDLVKTMRASIWALGP
LVARFGKGQVSLPGGCAIGARPVDLHIHGLEQLGATIKLEEGYVKAEVDG
RLKGAHIVMDKVSVGATITVMCAATLAEGTTVLENAAREPEIVDTANFLN
AIGAKVSGMGTDTITIEGVERLGGGYHEVVADRIETGTFLVAAAVSGGKI
VCKNTKAHLLEAVLAKLEEAGADVQTGDDWISLDMTGRELKAVNIRTAPH
PAFPTDMQAQFTLLNMMAKGSGIITETIFENRFMHIPELQRMGAHAEIEG
NTAICGDTDGLSGAQVMATDLRASASLVIAGCIAKGETIVDRIYHIARGY
DKIEDKLTALGANIERVHSDDL
>VF0746 lipoprotein
MRVILLAVSLILAGCASEPPQKTTDEPNAGRYQIDNDIAPDMPISVEHIE
DAHPRYEPKSLYGNKDYTLLGKDYPIVKEPKGFTQEGISSWYGKKFHGHK
TSNGEVYDMYSMSAAHKTLPLPSYVKVTNKDNGKTAIVRVNDRGPFHEGR
IIDLSFAAAAKLDVLKTGTANVKIEYISVAKPTNPQEWHAIDPNQYHIQM
VAVKNEQSADKIAKKLEAQFNAPTNIIKSGNVYRVRLGPFIDRDRADKTL
IEAKNGQYTSAFIIQELKK
>VF0651 amino-acid abc transporter binding protein
MSRIRHHRFIQSCLVISTLLITLTGCQVESEPKTKLEQIRERGILRVSTL
NNQLSYYIGSNGPTGLDYDLAKAFAEKLEVKLEITPAYTYSGLFPALERN
EVDIIAANMTITPERLQKFRPGPVYYYVSQQVVYKKGSWRPRNIKNLTQL
DENLTIVKDSSFEGTLIKLKEKYPNLDWNTAADTDVSELLKKVATGEIHY
TLADSVELSLTQRIHPDLAVAFEVTEDQPVAWFLQQTEDDSLQALLIEFF
GELKESGKLALLEEKYFGHVESFDYVDTRAFIRALESKLPKWEPLFKKYA
GDFDWRFLAALSYQESHWNPLAKSPTGVRGMMMLTLPTAQSVGVKNRLNP
EQVFVVVQNIYVE
>VF1656 hypothetical transmembrane protein
MIRLFVLCLSLMMSSTALAEDAQSIDNLQQFASLIRWSGVAASFFIILGA
WLFLRFIQSIVDGVSSQFAQRRMLMQKLQSFFQFFIYMSTAVAVFMLSFR
VDDRVLALIGGTIAVSVGFALKDLTASFIAGLTVMIDRPFQVGDRVTFEG
HYGDIIAIGLRSVRMQTLNDDIITIPNNKFLNEVTVSGNYGGLDMQVVIP
FYIGMDQDINKARDIIQEAASSSRYIHLPKPVVVLVKQTITDNYLAIQLT
CKAYVVDIKFEKLFETDITLRVMQEFRKANIIPPTIAIQSKLA
>VF1484 murein hydrolase export regulator
MWVILTLIVFYSARWFAKRFPHPVNNPLLLSVCIVIPILMVLHVPYETYY
ADNAFLSYLLQPAVVALAYPLYEQLPHIRANWKIILLACSVGSLFSMISG
AFLAVWMGADMQLVASILPKSVTTPIAMAISSQLEGEAAIAAILVLLAGL
MGAIFAYPIYNMLGIKSSLARGLTMGNVSHALGTAQAAEENPQDAAFSSL
ALVICGIITSLVAPIIYSFMVMMK
>VF0419 membrane-bound lytic murein transglycosylase C precursor
MVKNHTQLREYKYADIVRKASLKYDIPEDLIYSIIRTESSFNPYAVSWAN
AYGLMQVVPKTAGRDVFKLVKNKSGDPTPEYLFNPYNNIDTGTAYFHILK
TRYLKDIRHPTSKQYSMISAYNGGAGGVFNTFSSSRSRAINDINSLQPNQ
VYWALTKSTKMQRPDAT
>VF0169 hypothetical protein
MSKFTVFGGRGFIGSEFVKELRTQGHDVFVPEREDLSIYEDDLGTVIYSA
GYGDCQRDQFNVLTANVILLSSLLQKAKFDKLVYISSTRVYMNQNESSEY
SDVTICSKDNRRLFNLTKLTAEELCLKSERECLIIRPSNVYGLALNSNLF
LPSIIRNAIKNKHIDMYVDKNYEKDYVSVYDVVSSTLKLIKFPQEVNKII
NISSGENISANDIAQVLINKTGCSIKWKQTLNNTECFSPIDISYLKSLID
YKPRTLINDINNMVDSFIESI
>VF0926 sodium-type flagellar protein MotY precursor
MKKIFVTSALLVSFLIATPVLANKNYVAKPEQSKWTMLENSPLECRLSHN
IPNYGSAQFSSYANKKMNLDFELKMNRPMGETRAVNLVSMPARWMPGDGA
ESMLNLKFFKQFDGYVGGPTAWSMLAELESGRFPTFTYADWQSPKQMIEV
ALSPVLFQEQYNVFSMCIANLLPYSFEDISFTILHFDKNSDELNKASKKR
LSQIADFIKYTKDVDLVLVATYTDSSGGKNVNQQVSERRALKLQNYFESI
GLPADRIRVHSYGERRPIADNATPIGKNKNRRVVISLGRTII
>VF1939 membrane-bound lytic murein transglycosylase D precursor
MKLKLHWIGLALLAGCQTAPTPENTQPDTNSAITTPSKTEPKAAEVKPVE
KPAPTPQEQEDVWQRIAMQLEMPIPDNESVDYYRNWYIKHPSHLRTVAKR
AKPFLYMITVEIEKRGLPMELVLLPVVESAFDPFAYSHGSAAGLWQFVPG
TADRFKLERNWWYDGRRDVPAATTAALDYMEYFDSRFDGNWQHSIASYNS
GAGRVSRSIKKNQRLGKPTDFFSLDLPKETSGYVPKLLALADVIKNHEKY
GVELPPIPNKPVLEMVDPKQQLDLAIAAEFAGISITELQGYNPAYNQWAT
SPDGPYHLLLPIEHVDQFNANLKKNANKTMKVVRYKVQSGDTISQLAVKH
NTTTKIIEQTNDLNGANIRVGQYLLIPTASKGNKTYALSAPQRLKKTQAK
AKGKYKLTHKVKDGESLWSIARDNSISYRDLAKWNGMAPRDSLRVGQNLV
IWKNSSDGAIIRTVHYQIRQGDNLSSIAQKFSVAVTDIMKWNNIERGSYI
KPGQKLKLYVDVTKVNV
>VF2108 mechanosensitive ion channel
MADQGAVTDLATTGVANLEHWLTDNTELFITYGVNIISALAILFIGNIIV
KKVANSVSNVLKKKKMDKAVVDFVHTLVRYLLFIIVLIAALGKVGVQTAS
VVAVIGAAGLAVGLALQGSLSNFAAGVLIVAFRPFKSGDYVEIGGVAGSV
DSIQIFQTILTTPDNKMVVVPNGGVIGSPITNYSRHATRRVDHVIGVSYS
ADLKKTKEVITKVLESDPRVLKTPAPTVGVVALADSSVNFVVRPWCKTAE
YWDVYFDTLQAIKEGLDNEGIEIPFPQMDVHLNKVD
>VF0152 ADP-L-glycero-D-manno-heptose-6-epimerase
MIIVTGGAGMIGSNIVKSLNNKGFNDILVVDNLKDGKKFKNLVDLDITDY
MDKEDFITQIMAGDDFGPIEAIFHEGACSATTEWDGKYIMMNNYEYSKEL
LHFCIEREIPFLYASSAATYGETDTFIEERAYEGALNVYGYSKQQFDNYV
RRLWADAEEHNETLSQITGFRYFNVYGPREQHKGSMASVAFHLNNQMNAG
DNPKLFEGSDEFKRDFVYVGDVAAVNLWFLENGVSGIYNCGTGRAEPFRA
VAEAVIKHHGKGEVETIPFPEHLKGAYQEFTQADLTKLRAAGCDVEFKSV
ADGVAEYMAMINK
>VF2562 glucosamine-1-phosphate acetyltransferase
MNFSAVILAAGKGTRMYSNKPKVLHTLAGKPMAKHVIDTCEGLGAQNIHL
VYGHGGDQMKAELGEERVQWVLQAEQLGTGHAVNQAAPEFADDEKVLVLY
GDVPLISAETVENLLDAQPTGGIALLTVVLDNPMGYGRIIRRNGPVIAIV
EQKDATEEQKLIKEINTGVMVATGGDLKRWLAALKNENAQGEYYLTDIIA
AAHDEGRAVEAVHPVSPIEVEGVNDRAQLARLERAYQAAQAQKLLEQGVM
LRDPSRFDLRGTLQCGMDIEIDANVIIEGNVTLGDNVIIGAGCVLKDCEI
DDNTVIRPYSVIEGATVGEECTVGPFTRLRPGAELCNDAHVGNFVEVKNV
RLGEGSKANHLTYLGDAEIGKRVNVGAGVITCNYDGANKFKTIIGDDVFV
GSDSQLIAPVTVANGATVGAGSTVTKDVNENELYISRAKERRIANWQRPT
KK
>VF0133 glycosyltransferase
MKIYHINLARGFSGGEQQTLALIKQHQKQQQEIAVIALANSPFHQAVSDL
GCEVITVRHYLLGHTISLPKDAVLHVHEGHAIYWAAIQHKVSQTPYIITR
RLDNPIKKKWLTTFAYSNAAAIVGISTCVSEVVRTRLPQQHIVTIPDSPV
IYPVNHSEVANIRERFKDKFLVIQAGNMIPHKGFDVTVNAAMRLKDPNVH
LCLLGDGKQRSELEEQASGLANISFMGRQHNMGDWFAAADLLIHPSYTEG
LGSVILEGMNAGLPAIGSHAGGIPDIIEHDKSGLLIEPGNSVELAENIEK
IANDATLKERLIEGGREKLTSFMIEHTAALYFKVYQRALQHD
>VF0140 UDP-N-acetylglucosamine 4,6-dehydratase
MNSILSLIGRDTELFHQDINANEKELQSVVSQSRFLVLGGAGSIGQAVTK
EIFKRNPQKLHVVDISENNMVELVRDIRSSFGYINGDFQTFALDIGSIEY
DAFIKADGQYDYVLNLSALKHVRSEKDPFTLMRMIDVNVFNTDKTIQQSI
DAGAKKYFCVSTDKAANPVNMMGASKRIMEMFLMRKSEEIAISTARFANV
AFSDGSLLHGFNQRIQKNQPIVAPNDIKRYFVTPQESGELCLMSCIFGEN
RDIFFPKLSEALHLISFADIAVKYLKQLGYEPHLCESEDEARELAKTLPA
QGKWPCLFTSSDTTGEKDFEEFFTDKETLDMARFDNLGIIKNDSLYQQEL
LELFEQKIGQMKTDRQWTKEEIVQLFFIMIPDFGHKETGKYLDSKM
>VF0300 conserved hypothetical protein
MLKKGLLTGLIAISASVHASEIDIEDADTSSSSPNSIEIDYGNDRSLSQN
CSLESVYTSGTNSHVDEEKYYLSKDDCEAGTKELTLEKKPSINPVISQLE
AEMEEPDTTPPSPWKSQIEFGYQSSKGNDDSQSLNGRLEASYTAGQHRHT
GEVKYYLAKDDGETDKDQLSLNLQSDYKISPDYYLYANFKGLNTKYSAYF
NDYTFSGGLG
>VF2162 multimodular transpeptidase-transglycosylase PBP 1B
MAEKKKTPTKAAPKKTAAKKKAPAKRKTSSKKKAQSSRPFWKSLMILGFK
LSLVVLAILVIAGIYLDTVVKKRFDGQLFSLPTVVYSRVLTLSPGQNISL
KTVQNELDLLKYQKVRQPQRPGEYSSSSTKIELIRRPFEFQQGPEPDRHV
MLYFNSEGLQKIENRSVMKQMGFLQIEPQFLGMLDADDDQQRLFLRREQF
PEVMVDALLATEDRDFYQHDGVSPLAIARAMVVNAKAGRTVQGGSTLTQQ
LAKNLFLSRERTLWRKVREAYLALILDYRYSKDRILEAYLNEVYLGQTGG
EAIHGFGLAAQVYFGRPIEELRIDQLAMLVGMVKGPSYYNPMRFPERVKE
RRDLVLRLMMQEEILSPHQYEMAASRPLDVKKRATIATRQPAYFQQLKWE
LKEKAGKAYQKGEGLRVFTTLDPLSQQKAEQAVERTVPQLEKRAGKGLEA
AMVIVDRQSGEIRAMIGGSRTGFDGFNRAINAKRPIGSLVKPAIYLSALE
TPDKFSLATTLDDKPIALKGSKGTTWTPRNFDRKFRGEVPLYYALSRSLN
VPTVNLGLMVGLSKVTDTLVKLGVDANEINQVPSMLLGSINLSPYQVAQM
YQTIGNGGRKAALTALKAVVDNDGNLLYENFPKSAAVVPEQATWLTVYGM
KRTVSEGTARFLNSKYSWAALAGKTGTSNDSRDSWYAGIDGREVAITWLG
RDDNKPMKLTGSSGALRVYADYLSMRSPEVLQLPWPNEVTAAGFDLQSNK
TLEPDCSGRVKLPIWDKKGQYKAECEKNKPAAWLTDIFGF
>VF1011 hypothetical protein
MKKTLLALAIASISASAFAVDTSSQNSKNEDMFAFDPMHKDQFSVSGSVG
VGGYYDTGSKAFYDDWATGLTLAVNYRNNRIVGYFETDLMLNYTTDNATS
PILKDGSEFATDVDKAWLGFDTGFGIASFGWENDTALDAVDGAGDNTYEF
GASAGDASDAFNVVKFQGSTSGFAYGVSYFETDDTHVDAEKGVNGYVGIE
QEIFNVYAGYELRDEATRTLRKLPNGAKIEAVDADYQVMTVTGNVKLGEV
KLGANFWIEDTSGKNLDKTNTGYYLSAGYAVTEDLTLAAGYAANTDEVTG
MKDLDQSYMNVAAMYTLAKNMDMGIDIKQELDSGYNNVDEETYVFAAGYY
YF
>VF1388 dTDP-glucose 4,6-dehydratase
MTSISVLGCGWLGLPLAKHLVDTGFMVKGSIRSSNKISELEKNHIKPYLL
DIDAVEQSWSQFLTSDVLIIAIPSKNIEGFTSLIPIIEASSIKHVLFVSS
TSVYEDANRVVTEEDATIPSSALSQIERLFMQSTKFTTTVIRFSGLVGYS
RNPGRFFAKSGRSVSNPDVPVNMIHQDDCIGLITQIIKQEKWNEIFNACA
DTHPSKREFYTQATQRIGVETPTFIESNEQTFKIISNHKIKEALGYEFIH
PDVMNITYDS
>VF1815 lipoprotein
MKRVWISCCILLFVSACSQTPEQTEEELDTTQQIDTEYEETHVSDPLEGF
NRVMWGLNYDYLDPYLVRPVSIGYVEYTPTPIRYGIANFLANLDEPSSMI
NNLLMGNGNMAMVHFNRFWLNTTLGLVGLIDIASAADIQKPDSKSFGDAL
GHYGVGNGPYFMLPGYGPWTLREAGDFVDGLYMPLSYLNFWQGLGKWGLE
GMESRVQLISQEPMLEASPDPYVLTRDVYLQRQDFKAEIEPEVDLDAEDD
IDDYLDEIDE
>VF0193 UDP-2-acetamido-2,6-dideoxy-beta-L-talose2-epime rase
MKKLKVMSVVGTRPEIIRLSRVLAKLDEHCEHILVHTGQNYDFELNEVFF
NDLGVRKPDYFLDAAGKNAAETIGQVIIKVDQALEEILPDAMLVLGDTNS
CLSAIPAKRHKVPIFHMEAGNRCFDQRVPEETNRRIVDHTADINLTYSSI
ARDYLLAEGLPADRVIKTGSPMFEVLNHYMPQIDASDVLSRLGLKQGQFF
VVSAHREENVDSPKQLAKLAESLNCVAEYYNLPVIVSTHPRTRNRIEAQG
IEFHKNIQLLKPLGFHDYNHLQKNAKVVLSDSGTINEESSIMNFPALNLR
EAHERPEGMEEASVMMVGLSVERVMQALQILESQPSGDERLLRLVYDYSM
PNVSDKMVRIIHSYTDYVKRVVWKEY
>VF2298 multimodular transpeptidase-transglycosylase PBP 1A
MKFIKALLIVTLVCIILGVTTIFGFYQYVKPELPDVATLKDVQLQTPMQV
YSRDGKLIAQFGEKRRIPLKLEEMPPHLLEAVIATEDSRFYSHYGFDPIG
ITRAAFAVLASGSAKQGASTITQQLARNFFLSNEKKIMRKIKEIFIAVHI
EQLLTKQEILELYLNKIYLGYRSYGVGAAAHVYFGKEVSQLTLGEVAIIA
GLPKAPSTMNPIYSVDRATTRRNVVLARMLDEGYITKQEFDDAKAEVVIS
KYHGAEIELQAPYIAEIARAWMVNKYGEEAAYTSGMNIYTTVDSKMQAAA
NKASIDNLLAYDERHGYRGAVKTVWEPKATPLDEEAITKHLKNEPSYGEL
MPAVVTSIKGKTATVDIKNNGVATIPWDGLKWARRFKTDKRQGPAPRRAS
DILAVGEQIYVRPLSQETKDDVTTTVWKLSQVPAANTAFVAMDPRDGAIT
SLVGGFNFVHNKFNRATQSVRQVGSSIKPFIYSAALYHGKTLASLINDAP
INTWDESQGTAWRPKNSPPTYVGPARLRIGLAQSKNVMAVRVLRDVGLDE
TIDYLTRFGFKKDELPRSETIALGAGSLTPVQMAQGFAVFANNGYYVEPY
YIDHITGPFGDEVYKATPKTICQRDCSHQNDEDSPYAKKVISAQNAFLTK
QMMYSNIWGGGSWRKGTGWNGTGWRAQVLKRRDIGGKTGTTNDSVDAWYN
GYGPNVVATAWVGFDNPSHRLGYTTKNDNMTKEEMSFGGEAGGKTAIYAW
VNFMKVALEGVPEEKLQLPANIIKVKIDRETGLLTNKNDETSMWEYFAGG
TQPKEYVEQDFQDTIYSSHDADGDGMEDESLF
>VF1954 protective surface antigen
MAMKKLLIASLLFGSVAAHSAETFVIDDIRFEGLQRVALGAALLKTPVRV
GDTMSQQDVAQVIQALFASGNFEDVKVFRDGNALLIKVTERPTIANISFS
GNKAIKEEQMQQNLEASSIRVGEALDRTTLSNIEKGLEDFYYSVGKYNAT
VHAVVTPLPRNRADLKFVFTEGVSAKIQQINFIGNEVFTDEQLLSRFNLN
VDVAWWNFLADEKYQKQVLAGDIEALRSYYLDRGYLKFQVDSTQVSISPD
KKGVYIALTIDEGEPYTVSGVKFQGELIGKEEEFKKLIPFENGEVYNGSA
VTSLEENIKRILGEAGYAYPQVRTMPEFDDENQTVSLIINVEAGNRMYVR
DIRFVGNTSTKDEVLRREMRQMEGAWLNSKSIETGKNRLNRLGFFETVDV
QTVRVPGSDDEVDLVYSVKEANSGSVNFGVGYGTESGISFQVGLQQDNFI
GSGNRVGINAMMNDYQKNISLDYRDPYWNLDGVSLGGKIFYNEFEASDAG
IVDYTNQSYGGSLTWGFPFDELNYFEIGVGYTHNKISNLEGYVQIEQYLQ
SVGDAYDSGDQTLIVSDFDVTLSWTRNNLNKGYFPTAGNYQRASYKITTP
NSDSQFFKAQYEVRQYFPLTKKHEFALLMRGKAGYGNGYGQTDGNDNLYP
FYENFYAGGFTTLRGFGSNSGGPKAVYAQGSNGGIGNNTSYAATDDSVGG
NATALASIELIVPTPFASEETRNQIRTSVFFDMASVWDTEFDYKEPKPGM
DGAQYYYDYSDPSNFRSSYGAAVQWMSPMGPLVFSIAKPVKIYEGDDEEF
FSFTIGRTF
>VF0468 lipoprotein signal peptidase
MTSDKKTLPLLKESGLRWLWLAGIIFMADISIKLFVMKEMGYGWANRIEV
LPFFNFLYVHNYGAAFSFLSDQAGWQRWFFTGIAISVCGLLVYWMRKAPQ
KDKLNNIAYALIIGGAIGNVFDRLVHGFVVDYLDFYWGNYHWPAFNLADA
AICIGAGLIILDGLRSGKKEQ
>VF1162 outer membrane protein TolC
MRDKFSEKMLFVFWALIASGLSSMSYALTIEDAWQATKQYDPEYLRSQLD
EKISETTIRSSKSALLPSARITATTAWNENSTYGIALEQIIWDSSKWSEL
DSSQASLLASQLKIKQSHNELAGRLISAYLDLAQSQGELRLAQQKFDEGR
KMLRIVELRYKAGKIRSVDLEDMRSNHLDEEANILANRLQVEDKKVRLIK
LISIEPTQVNEIKTNNLSQPKLIVNSKQEWLKLASNYSPDLLMAKQNIRI
SELETGKAKTGYYPTITASVGYSDNTRSDNTRSDSGLNASLNLSLPLDLN
SSIGSSVERAKLEVLRAKQDVRAVEIEIKSTISNRFNQLSLNWQRVEMAE
KQVASKELVLKSKQAIYKAGMAEASDIIEAHNSLFVSKSSLQSLLYQYWR
DRISLLKSVGRLDDETITLISQALQS
>VF0173 hypothetical protein
MIKKKKRILLVIPKFFNYEKNIKKHFELMGYDVDLIIDETPFRTILCNYI
PYMKLFFGFYVENKIKKLITKNDYTSCLVIKGSSLSLKALTIIESHIKNR
YLYQWDSLSNYPYQTMLLYFNHVLTFDISDSKHLNLEYYPLFSMIENDRK
ELSRNIDILFIGSFHSDRYKVLKEILCQYKDLNIYFYLYIPFLSYIKRIF
KGEKILLSDIRFFKIKPEKLSCFYNNSKCVLDIEAYHQTGFTMRTLEALY
CGCKLITTNDNIYTADFFDKKIISVIDRNDVLLDKSFIFNDENVEDNKIL
QVKNLKEWVVRFADD
>VF0748 cell elongation specific D,D-transpeptidase
MIKRKRTQIRDYHAETRLFASRAIISFSGIIVLIGLLLTNLYNIQINEFQ
DYKTRSNDNRIKIVPIAPNRGLIFDRSGNPLAENRPVFNLEVTPDKVSDL
SLLFTELQTILPITQDNIDDFQKERRRTRRFKSVPLLTQLTQEQVAIFSV
NQHKFQGVEIKAYLKRFYPYGKTLTHVLGYVAKINDRDLARLAREEKDAN
YQATRDIGKLGIERFYEDILHGTAGYQEVEVNSRGRVIRTLKYVPPIPGK
DIVLNLDIKLQKFVEKQLDGRRGSAIVLDPKTSAVLAMVSSPSYDPNLFV
HGISSKNYSALLNDPDRPLVNRSTLGIYPPASTVKPFIAVAALKEKIVTT
ETTRDDPGYWRIPNSKTKPFRDWKRWGHGTVNLKQSIEESVDTFFYQIAY
DMGIDRLSTWMMKFGFGDYTGIDIREESKANMPTREWKVARFRTPWYQGD
TIPVGIGQGYWTATPMQLAKATAVLTNHGKVQAPHLLKGIIENNKEVPYE
PEPYPPIEGVKDSYWQLAIDGMILVNNGRKGTARRAFAGTPYVSAGKSGT
SQVFGLKEDEEYNADEIAEHLRDHALFTGFAPAKDPKVIISLVLENGGGG
SSQGGPIARHVFDYVLLPKTEEAAKK
>VF0142 UDP-N-acetylglucosamine 2-epimerase (N-acetylmannosamine-forming)
MSKSLINKKVAVFTGTRAEYGLLFWLLKDIQNDPELQLQLLVSGMHLSPE
FGETYQQIEADGFVINEKIEILLSSDSSVGTAKSMGLGVLGFADSLARLQ
PDVLVILGDRFEALAAAQTAMIMRIPIVHLHGGEITEGAYDDAIRHAITK
LSYLHGTSTEEYRQRVIQLGEDPNRVQNVGAIGLDHLKRATFMTVPELSE
SLGFTLDKPFFLVTYHPVTLGNEVPEESFQALLNALDEYPDHQVILTYPN
ADDGGRRIIPILEEYARNNSARVLAIPSLGQVRYLSSVMHATAVIGNSSS
GIIEVPAFDVPTVNIGSRQKGRLAAKSVLNVEPNQQSISNGIQTAILRTY
KLIDEKVHNPYGQGDTSGQVIEMIKSLQFTPSKAFYDITFNYVE
>VF2515 glycine betaine transporter
MSRNKDKYSIDNTDYTVGQDNVQKWGFDVHNPVFGISAGLIALFLVAVAV
TDPESAKTVLDGFKWKIINAFDGLFMWSANIFVIFCLALIVSPFGKIRLG
GDKAKPDYSMVSWIAMLFAAGMGIGLMFWGVAEPVAYFTGWFETPLGVEA
NTPEAAKLALGATMFHWGLHPWAIYGVVALSLAFFAYNKGLPLSMRSIFY
PILGDRTWGWPGHVVDILAVLATLFGLATSLGLGAQQAASGFHHVFGMDG
GLGLQVAIIFVVTLLAVVSVMRGIDGGVKVISNINMLIAIVLLAFVALVT
FAISMGTIPTTVMGYVENIIPLSNPHGRVDEAWMHGWTVFYWSWWISWSP
FVGMFIARVSRGRTVREFITAVLIVPTLFTVLWMSIFGGVAIDQVVNNIG
TLGSKGLTDVSLAMFEMFDALPMGNILSMIAVVLVLVFFITSSDSGSLVI
DSITAGGKVDAPMPQRVFWAFMEGAIAVALLWVGGTEAIQALQAGAISTA
LPFTLILLAMCVSLLMGMRTEKYNRS
>VF0143 N-acetylneuraminate synthase
MTLIIAEAGVNHNGDEHLAFQLVDAAYHAGADIVKFQTFKAKNLVTEDAA
QAEYQVTNTQKQESQLAMLSRLELSYEVHHQLVKHCESLGIEFLSTAFDS
ESLDFLVNDLGLTRLKIPSGEITNAPLVLEHARTGCDLIVSTGMATLSEI
EAVLGVIAFGYVADKTAEPSELAFQQAYASEQGQKALKQKVTILHCTTEY
PAPMPEINLKAMDTLGRAFELPAGYSDHSEGITIPIAAVARGAVLVEKHF
TLDKNMEGPDHKASLEPQELMAMITAIRQVEVALGVGVKSPTVSEVKNKA
VARKSLVVAKAIQQGEIITEDNLTIKRPGSGMSPYHYWSLLNKPASKAYQ
AGDLIFE
>VF0188 hypothetical protein
MLLTIAIPTFNRAEKLDLQLKNICDQLIELKRDDICILVQDNHSDDQTTE
ISNKYMSKFESIDFVYFRNESNLGFDRNVNLCLTNSKSKYTWILSDDDDL
NSNAILTIISEIDRNVGKFNFAFINYIVRSSEGVCANKCPNIKTKLVNGM
NLLYEIELSHSFISSCIFEVKSWLNKDVSEYFDSLWIHLLVARDIVPNGK
TLLISEPVITMNMPSLEESRDSVIYEDKLEFYTNAHIRISKFCHELDNYG
YSNDLKQYLVNKCRDYDRRQVINYKLTVERNSFKDMVRIAKAYYSVKNNT
WSYFLVLLPLILLPREFFKALKWLKYVLK
>VF0192 UDP-2-acetamido-2,6-dideoxy-beta-L-talose4-dehyd rogenase
MKILVTGANGFIGKNLCFQLEEQGFTDLIKIDRSNSTEELNEALKSADFI
YHLAGVNRPQNDDEFKLGNADLTSHIISKLKELNRTPPILLTSSIQAEQS
NAYGVSKALAEDALNSYAEQSGAKVYIYRLPNVFGKWCRPNYNSVVATFC
HNIVNDLPLTINDPSAKVNLVYIDTVCEHFIHHLSNNEPGGEQSIKLIYP
TTVGDIATALESFKASKTSLVTENVGTGFLRALYSTYISYYSPEQFSYTI
PAYTDPRGSFCELLKTKDAGQFSFFTAHPGITRGGHYHHTKNEKFLVIKG
EAKFRFEHIATGECYELDVTGEDYKVVETVPGWTHDVTNIGESELVVMLW
ANEIFDREKPDTFTKPL
>VF1121 BCCT family transporter
MKKHFELIDKPTFFGAILLLCAVVVPLLVFPAEGAEWIAVAKTFMTDKLG
FAYLGLGLAAFFFMIYIVFSDIGQIKLGDPDEKPEFALASWAAMLFCGGI
GASILYWGTIEWAYYYQNPPFQLEAGSEEAVRWAATYGLFHWGPIAWCIY
MIPAIPIAYFFYVRKQPVLKVSAALMPVIGEANSFGKLGKVIDVLFIFGL
LGGAATTLGLAAPLINEGISYLFGIPATTGSQILVLMVCTAIFAYSSYMG
MDKGIKILSNINFWGALGLLLFVLVCGPTIFMLETGLDSIGRMLSNFFVM
ATWAEPFGGMGTFADTHFPQDWTIFYWAWWLVFAPSMGLFVARISRGRTI
KQMVSGAVFFGSLGCAMYFIILGNYGLSLQLSGELDVVGILNSEGATRAI
FSVLEQLPFSTFVIAVFTLLCVIFTATTFDSISYILASVVQTNVTEDPMR
WNRLFWAFTLSFMPSALMFMGGLATLQTAAIVGGLPLLVIAIMLMISGVK
AAMLDLSHQDNYVDPVINISDLPDVDPWSKEGQALARFEQLRDNAIEAAD
LEREANDAIWMLKKQLRKEALARGESSVDLGDAPDEIIEKLRQLTDDSTN
AKEAKLAASELAQEARVAFDALMRQKVEEETLQANEEAKLAIKTRLNTPS
>VF2234 D-glycero-D-manno-heptose-7-phosphate 1-kinase
MKPTLPNYDQSSVLIVGDVMLDRYWGGPTSRISPEAPVPVVKVEKIEERP
GGAANVAMNIAALGGDAHLVGLVGEDEPAQALTTTLESLKVHCDFVALPE
FPTITKLRVMSRGQQLIRLDFEDSFHDVAAEPIISRMQQALSSVKAVVLS
DYAKGALEHVQLMIQEARKVNVPVFIDPKGADFERYRGATLLTPNMLEFE
TVVGKVKDEDDLVAKGQQIIEEFDFEALLVTRSEHGMTLLRRNMEPLHLP
TQAREVFDVTGAGDTVISVLAASVSTGKPLDEACALANAAAGVVVGKLGT
STLSTIELAEAIHGSQDSGFGIIGEEQLISAVKQARARGEKVVMTNGCFD
ILHAGHVSYLNHAAELGDRLIVAVNTNESVQRLKGPGRPINPTDRRMAVL
AGLGAVDWVVPFSEDTPQRLISQVLPSLLVKGGDYAIEDIAGGAEVIAAG
GEVKVLNFEDGCSTTGIIEAIKGGRG
>VF0165 chain length regulator (capsular polysaccharide biosynthesis)
MSQAINSTRDTSTSDEIDLAKLFGQLIDGRWLILSITTLFAIAGIAFALL
STPIYKADALVQVEQKSNGGMSALVGDMGEMFASESSSTTEIEIIKSRMI
LGDTVDALNLTTIASPQYMPIIGKGLSRLMGEEKAIKVSRFDIPRYVDKP
NFTLVLDNAEQGTYTLFDGQERKILTGKVGVLADKNDYRVFVMQLEGNTG
DVFDVSKISRFDAILALQQSLSISEKGKQSGVLQFSLEGENKAQIEAIIN
DVSQNYFLQNIARNSAEAEQSLEFLQAQLPAIKDKLTTSENVLNDFRLER
KSVDLSLEARSALDVLVKLEAQLNELTFKESEISQRFTKDHPAYKSLIDK
RKVLLAEKDRLNGQVQKLPKTQREVLRMQRDVELNQEIYIQLLNKTQELN
IVKAGTVGNVRILDTAQAYTHAVKPKKPLIVVLATLLGGMLSVAIVLLKA
AFHRGVENPDEIEALGIPVYASIPKSNWQEKLDIRYNKKKVKHLETLLAE
SNPADLSIEALRGLRTSMHFAMMEAKNNVVMITGPAPNIGKSFVAVNFAA
VIAKTGQKVLVVDADMRKGYMQRYFGMRWDNGLSDYLSGKLSLEESIQKS
EVPNLDVLTRGQVPPNPSELLMTKRFSDFIDWASANYDLVLIDTPPVLAV
TDPSIVGALAGTTLMVGRFDQTSVKEIDVARHRFEQAGIEVKGFILNAVE
KKASSTYGYGYYNYSYDSDK
>VF0883 nucleoside-diphosphate-sugar epimerase
MAHRIIIVGASGYIGSQLIPLLLEQGHQVIACARNIQYLTDRVQQHPNLR
CEYLDLENKTTIEPLLFDCDIGYFLVHGMSHGHDFIDYEVSLAQNFADAA
EQSQLKRIIYLSALQPENHQSQHLLARQKTGEILRSTGITTIEIQSGIII
GAGSAALEIMTDFINHLAIILCPKWIHSQANPIAIDNLNDYLIQCLDIEV
SNSLSLEAGGPDTVTYLQLFNLLAKRLNKSIKIIPTRFISPKFAGLWLGI
ITSVPSELGRALLAGIDHDLLADNSKIQQLMPQTLTPLPEALKLANHTSA
NSLQGEIWGFDPSALRRWQPDYGYYPKQAGASFTTNASANSLWKVILQLG
GPEGYFFANGLWRTREWLDPLLGGSFPIRRKPKSDQLQLGDYIDSWKVIR
CENNEFLSLLFGMTAPGLGRLEFSIKELENNTRELDVRAWWHPKGFWGLM
YWFAMFPAHLFIFKGMVKAICKKAEKEEKG
>VF2433 glutamate racemase
MPKHILIFDSGIGGLSVYKEIKYQLPLAKYIYAFDNAAFPYGELTESVLI
ERTTHIISKLCSKFPIDIVVIACNTASTVVLPSLREKLDIPVVGVVPAIK
PAALVSNKIGLLATPATVKRSYTYDLIKSFAPISDVQLLGSTRLVEMAEE
KMIGIDVDITELKEILSPWQNKVDTIVLGCTHFPFLKNEIKKALGNKILL
IDSGEAIARRVKQLLNGDEVESAVLFEGEVFCSAPSIKEEALNHTFKELN
FSSLQCLGYPKF
>VF1915 D-alanyl-D-alanine carboxypeptidase
MTYQELTGQSFQHLSKLSPHRQLHHDCILPFKALSDAAHQAGFTLTIASS
FRDFERQLLIWNNKFLGIRPILDDNGHELDPSSLNDLEKIHAIMRWSALP
GASRHHWGTELDVYASNTLPEDVQLQLEPWEYNTGHQAEFSSWLNKNAPK
FGFFFPYKTDKKGVAIEPWHISYKQNSNAYMSQLTPEMLLKAWEGVDLAG
KETIIKHIDTLFVRYITNIDKE
>VF2133 periplasmic component of efflux system
MGKYTSAFLSYLIHRPWIISFLLFLSLFLWVMSGPSQAEESSGIKETSTF
SIPLANVVIEQFESTPTHKTISLYGRTSPDKQAILGAQVAAQIEELLVKK
GARVTKGQPIARLDMADLDLQLSQAKAIYSVRMKEFNAAKELKRKGLQGE
VAFSQSQASLAEAKARVRNAELILENTTITAPFDGIVEHLFIEVGDFVSR
GDPVAKVVVLDPLVIDVNVSERHISQITKQQKAEVSFINDVSIEGYVRYI
SKISSLSTNTFSVEIEILNIGGKIPAGISSEVEINLALQSAIKVTPAMLA
LNESGDLGVKTAIEAEGHSETNYKVKFVPIQLVKAEDDGVWLTGLGNEVD
IITVGQGFVRDGDFIHVQRK
>VF0187 hypothetical protein
MVIMKNNITVCIPTFNRCESLKKTLGHLLSSKSISFSVVVSDNASEDDTW
EYLNSLDDTRLIISRNETNIGFTGNILKVLELSPTDFILFMSDEDFVILE
NIEEIIRTNIDDDVGVFYGGVLHENNSTYYYKYNKKTWKKKEALNKVVLS
HSYMSGMIFNKKYLDLNKFNTSIADEDVVLYPHEIMVYMILCNGGKLVTD
SLPIAKQGEAVESEAIIKYKYYEYNERLKLFKQYCRVVSNLDYGLIESRI
FFKKMAIIASCVFVDEVLIKKIKPKQYLSEIFSLNCGWLFKLQFVTYSSA
VFLMRKLKN
>VF0344 glycosyltransferase
MTEKITVIGTRGIPNVLGGVETHCQHLYPEIHRQFDNDICVIARSPYVDY
KISSFQGVQTKAVWAPKKKSLEAIIHSTLASLTTLFDGSKVIHVHAIGPG
LVVPLLRLLGKKVVFTHHGPDYDRQKWGGFAKRILKLGEKLAATYANEII
VISEVINDIIKEKYNRYDAHLIYNGVKLPTQLPQEKIDSTLSKFALTAGN
YFVAVGRFVEEKGFHDLIDAYQQANLNIPLVIMGDTDHPTPYSEKLKQQA
KNVDGVILTGFLKGEELQAIFSQAKTFVMPSYHEGLPIALLEAMSYSLPA
IVSNIPANLEVKLTPDTYFSIGNTEELTLQLAQHAKNEYSSINYASYLEY
YDWEKIATQTMAVYQRALTKKVLSGQS
>VF1280 carboxy-terminal processing protease precursor
MNCRFRVSLIAAGVMLAASAHALEAKVLDAKFSETDLPVLAAETQHATAS
KRVTSRFTRSHYKHFSLDDDFSVAIYERYLDMLDYNRNVFIQADLASFAP
LSTQLDDQLKVGDTKAAFDIYNLSLKRRFERYVYALSLLDKEFDYTVDES
IELDRSEAAWPKDEAELNELWRKRVKYDALNLSMAGKDWPEIQEMLGKRY
NNALKRLTQSHNEDAFQLYINAFAREVDPHTSYLSPRNAEQFQSEMNLSL
EGIGAVLQATDDYTVIRSLVAGGPALTSKKLSEGDRIIGVGQEGEKIVDV
IGWRLDDVVQLIKGPKGTKVKLEILPEGKDSKSHTVTIVRDKIRLEDRAV
KSEVIEQNGKKIGVLEVPSFYVGLAEDTKKEIAELKEKDISGIIVDLRNN
GGGALTEATALSGLFITAGPVVQVRDSYGRVNVNADTDGEISYTGPMTVL
VNRYSASASEIFAAAMQDYGRAVILGENSFGKGTVQQHRSLNHIYDLFDK
PLGHVQYTIQKFYRINGGSTQNLGVVPDIAFPTAIDPKDTGESVEDNALP
WDSIKAADYAKTNQIAETIEPLAKKHVERIKTDEEFGFIQEDIARYKAEK
DITSISLNKKVREKESDDADARRLTRVNERQKLLGKEEFKTLDDIPKDYE
VPDAYLDEAVSITIDLALMNQKK
>VF0199 hypothetical protein
MLFFDNLHPSRIIVGEQSERAQVFADLLVEGAIKENIEVLLTNSTEAEAV
KLFSNTYLAMRVAYFNELDSYAEAHGLDARQIIEGVGLDPRIGNHYNNPS
FGYGGYCLPKDTKQLLANYQEVPNNIIGAIVDANRTRKDFVAESIMKRNP
KVVGIYRLIMKAGSDNFRASSIQGIMKRLKAKGIEVVVYEPVLKEADFFN
SRVIEDLAEFKQVSDVIVSNRMMEELSDVESKVYTRDLFGSD
>VF2405 curli production assembly/transport component CsgG precursor
MKYSIYYLFILLLAGCSNSIDIPETSESPTLMQRGANYIDLISLPKPQGK
IFVSVYDFRDQTGQYKPQPNSNFSTAVPQGGTALLTMALLDSEWFYPLER
QGLQNLLTERKIIRAAQKKQESISNHGSTLPSLLSANVMIEGGIVAYDSN
IKTGGAGARYLGIGGSGQYRADQVTVNIRAVDVRSGKILTSVTTSKTILS
YEVSAGAFRFVDYKELLEVELGYTNNEPVNIALMSAIDSAVIHLIVKGVQ
QGLWRPANLDTRNNPIFKKYASETNQIL
>VF2426 UDP-N-acetylenolpyruvoylglucosamine reductase
MQILLNKTLKPYNSFSVNESADLIIQADSIQDLIDIWSDKKYTDMTKLPL
GRGSNTLFCNHFNGVVVLNRLFGKSVTETDTDYLLKISSGEDWPALVEWC
VDNGFAGIENLAMIPGCAGSAPIQNIGAYGLELKDICESVEYLDLETLQI
KTLKNSECLFGYRESIFKHELKDRCIITAITLRLNKQWQPVLAYGPLSDL
RNSKTTPKNVFDKICEIRSKKLPDPNVIGNAGSFFKNPVISEEHYLALCE
TYPNLPAYDVTEGKKIAAGWLIDNAGLKGFKINGAQVHQEQALVLINTGT
ATSEDILELANHVKNSVLDMYDIELEHEVRFYLNGEESFLSELFDERTH
>VF0299 outer membrane protein
MTIPFRVVWVNQVSNTEKLLLEVEFGPGFRYQNPNLDEIDDDDLILPETV
QEPIIRTNVRTSWKALSNLTLAGEVTVTAGHSNTRVDSEVSVTNNITEEI
ALKIAQSQQYLDRVPPGLSNTDSVFSINLLFSF
>VF0663 N-acetylneuraminate lyase
MKKLTGLIAAPHTPFDSSNNVNFEEIDKIAKHLIKDGVKGIYVCGTTGEG
IHCSVEERKAIAERWVSASNNQLDIIVHTGALSIIDTLELTRHADTLDIL
ATSAIGPCFFKPGSVADLVEYCATIAAAAPSKGFYYYHSGMSGVNLNMEE
FLIQADKHIPNLSGLKFNSGDLYEYQRCLRACDGKFDIPFGVDEHLPGAL
AVGAKSAVGSTYNYAAPHFNSIIEAFNRGDQEAVFNKMTNVIELIRVLVD
FGGVAAGKVAMELHDINAGDPRLPLMPLTAEQKVTVATRMRNAGFIQ
>VF0722 putative lipoprotein
MKKVIIALSALFLAACSAPSDPQLDIQPKASSNAHQIVDGIKLTLDSSDL
RTAQYVAVIDNGRQNVQPIHAKQNLRVTLEDALSSQLKTQGFVITVDSDN
TLRLDIIEALVSVQHSLMSNEIKTQVKLQITAETPKGKFVKTYNGVSEKT
GSMSADNQDIEQVLNDLLNAVLDKIAVDEELQTYIKGNF
>VF0171 hypothetical protein
MEWSDFSDDYDMLFCDSAVAKSIKQDIYVNKLSRIKSIVKVLFLFFRKNK
CIDFKYNGINNLYVLESMTPSNFKTINPIFELDKSSKLIIVTTPVFQRID
NVRYRGNLFNIDDYTFVNIGDFINSLHFCRRFNNKFRFVNIFQLIFLYLR
ASSLNNVLNELFSNVKCNNIILTNDTLGLSNLIVQNSRVFNIKNYVLQHG
LPTKFYFPTSADNYIVWGRRFVSEFKNKGARSKLYSLGSPKVDEVMKYCF
SDAKYNDFLKRYNISNNKKIFTYFSNSHAPELDKKVHEINIKLLNGLISH
KDYHVCIKLHPSESMQFIKEVLQPYDGKYTIIDHEDDVYDLVKFSSYCAS
IYSTLLIESMCLGTYTFQFNATKSHKIPDYSNGGGCVEINSFEQLELSLN
ASNKNKILNQQLKYTENYFSNQGTSSEKILELIHERNCI
>VF0558 soluble lytic murein transglycosylase
MKYTQYKLGMMTALCIGMNVQVVDASPVDTWRAQYQEAKTLLNEKKYDEY
KKVRAELDGYSLAPYLDYRELRMDLSSKTPDDIRLFKHNHQSLPIGNSLS
YQYLVILGLNERWAEFIDYFPNEPSSKNLQCYYYQAKNKLGDKATAWKGA
EQLWLTGSSVTYECDDLFQDWAEAGKLSDDLIIERMLLVYKARNNNLFSY
LEKMLKADAAKEKAQHIVTLFNDPDLLESFSKSNKKTEFSKQLTLISMER
EARKNPKKAIEILPDIAKKQLFTQEELVQVKRRIVSSIMSTESAELAQWR
DKELAANPEDSFIERRIRVAIRAADWDDVSNWIEYLTPTAKNSLRWQFWT
AQIESKEGEQDKADARLKKLLGQRNFYSVAAANILGEPIQYPMNTAPRNI
KPIKDKYSVELARIKELIAIDEIPTAKSEWEYLLNRASKTEVKELASYAA
QHRWHHFTVLATIKGRMWGYLSLRFPIAHQWWFNHYSKELGLDKVTLMSL
SRQESALYAEAQSPVGARGLMQIMPATAKYTAKKIDYDKYEGVDSLNDVD
VNIHIGSNYLKGLLDDYDGNRIFALAGYNAGPHRVKRWRAVSDEKLDAYA
FIEAIPFKETRGYVQNILMFETYYRSLLGEKGAFLSEKELNLKY
>VF0178 3-deoxy-manno-octulosonate cytidylyltransferase
MNVKVVIPARYGSSRLPGKPLLTLLDKPVIWHVIERCKEAGIEQNDIFVA
TDDQRIIDALRDESIQVVLTSSEHQSGTDRINEVAQIKGWDEDTIIVNVQ
GDEPMIPYRLIQRIVSFTQLNPSYHITTAVVPLVSQDDFVNPNVVKAIIG
YNGRALYFTRSPSPLNRDNSSDLSLAKRHIGIYAYRASALKQFCSYSEDE
LEQYEKLEQLRALSHGMSIGATIFDGFVPHGIDTIDDYENIKKIMEENIL
>VF2131 cell wall endopeptidase, family M23/M37
MILSKLTRIPVIHRILIGLCSAGIVVTIATIPDTVAPDSGFYKLTVGQTY
PIEIRKEALISHEKNSLNQQLSWETHTVKSGESASVLFSRIGLGYSQLLK
LTSSDKEIENQLTRLRPGDKLKFGFNQGQEIVQLIRPISKFETYRISKAG
DGYIGLFEKQDIETQLNYTKATITSNFWNASIGAGLNPNQIMELAGIFGW
DIDFALDIREGDNFKVLYEEKYVEGEYAGKGNIIAASFTNRGDTFTAIRN
DKNGNFYEPNGRAMKKAFLRSPINFRYVSSNFNPRRLHPVTGQRKAHRGT
DYVAPVGTPIWAAGDGVVDKAGYNQFNGNYVFIRHSNTYITKYLHMTKRY
VRAGQRVKQGDTIGTLGGTGRVTGPHLHYEFLVNGVHKDARTVSLPQSKS
LTGKDKKEFEVVAKERLKQLEQYGQFIVGNHPVINHE
>VF0346 hypothetical protein
MTKLPFISVIIKTYNEEAGIEKTISSIKKNMGVYPHKIIVADSLSTDNTQ
DIATKMDVTVVSLTEPEDRCCGVGHQLGYLYSEGDFLLLLDGDMELESGF
IEQGVSFLLENPQYAGVAGSVEMDDVDSYEFKSRKQRLHQIYPIGDCSHL
GGGGLYRKTAIDEIDYLTNRNLHAYEESELGMRLTHAGYKLHRLDVPYFF
HTSYTMSSLALMKHRWKGGYLFAPGELVKGAFGTPLFSHALKTIKNEAIF
AVYLFILFASLLSFNPILIGATSLPLFAFIGLKTIKNRSIRDALQSVLNL
SVFAAGLIKGLFIPLKDPKTPPPHTVINEGKK
>VF2206 UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase
MMQLSELLLPWCDLNQSVAISSMTLDSRQVSPGCLFVAIKGHAVDGRQFI
SSAIEQGAVAVIADADKENIAGTVKVIDNAIVVYIDSLYTQLSAIAGAFY
QADKRNMQLVGITGTNGKTTISQIIAQWTTLLEQPAAVMGTTGNGLLSDL
KPALNTTGSPIEIQQTLTELENIGAKLTALEVSSHGLVQGRVNALSFDAA
VFTNLSRDHLDYHGDMANYAEAKKLLFTSHRPKNSIINGDDQVGCQWLKE
MPHAVAVSLNEENISFHSGKKVFATSVVYSTEGIKLSISSDWGNVAFSVP
LIGAFNASNILVAFAALLSLGYDIQALAQTASQLNAVIGRMELFATDNKA
KVVVDYAHTPDALDKALQALRVHCEGKLWCIFGCGGDRDTGKRPIMASIV
EQQADAIILSDDNPRSEEPSLITDDMLVGLKNAESAHVIHDRFEACQFAL
SQANENDIILLAGKGHEDYQVLADKTVHYSDRETAQTLLGLQS
>VF0197 UDP-N-acetylglucosamine 4,6-dehydratase
MQFLQPIWSMPRPLKRLVSIVVDILFIVFAFWAAFATRLDGIEIYMQDVS
YWKLLAVLIPCTLLVFTKSGLYRAILRYLSLHAVLSICISAIISSAFIVF
ISYFNYLYMPRSIPVIYATYLVMLCGGSRLIVRVLVSDLLGKQKKKVLIY
GAGSAGLQLANMLRQGKEFHPIAFIDDDRKKHKTTMQGITIYRPKYLERL
IKKHCISTVLLAVPSASQVQKKVIIESLAKLHVEVLTIPNLDDLVNGKLS
IGQLKEVSIDDLLGRVAVTPQAELMEANIKDKVVMVTGAGGSIGSELCRQ
IILNKPTTLVLFELSEFSLYQIEHELSQIIANQQLSINVVPLLGSVQRLN
RLAATMKAFKVQTVYHAAAYKHVPLVEYNVVEGVRNNIFGTNYAAQAAIE
AKVESFVLISTDKAVRPTNVMGTTKRVAELGLQALAQVENAKPNGTRFCM
VRFGNVLGSSGSVIPLFKKQIAQGGPITLTHKDITRYFMTIPEAAQLVIQ
AGAMGKGGDVFVLDMGESVKIADLARNLIHLSGLEVRSDENPDGDIEIRC
TGLRPGEKLYEELLIGDNVGKTAHERIMTANEEFLPLNEYNQLLDDLDTA
CHNFDHATIRQLLIDAPTGFAPVDGIGDLVWKAEQ
>VF0342 UTP--glucose-1-phosphate uridylyltransferase
MIKKCLFPAAGYGTRFLPATKSMPKEMMPVVNKPLIEYGVEEAINAGMDG
MCIVTGRGKHSLMDHFDKNYELEHQISGTNKEELLEDVRELIDSAHFTYI
RQREMKGLGHAILTGRELVGDEPFAVVLADDLCVNEEQGVLAQMVALYKQ
FRCSIVAVEEVPDNETHKYGVISGEMIKDDLYRVDNMVEKPEPGTAPSNL
AIIGRYILTPDIFELIEQTEPGKGGEIQITDALLKQAQSGCVLAYKFKGK
RFDCGSVEGYIEATNHCYENIYLKDKKSSELAKKVTGKK
>VF0167 Glucose-1-phosphate thymidylyltransferase
MKGIVLAGGSGTRLYPLTRGVSKQLLPIYDKPMVFYPISTLMLAGIKDIL
IITTPEDNAGFKRLLGDGSDFGINLEYAIQPSPDGLAQAFIIGEEFIGDD
SVCLVLGDNIFYGQSFGRTLRKAAARDYGASVFGYHVKDPERFGVVEFDK
DYKALSIEEKPENPKSNWAVTGLYFYDNRVVSFAKKVEPSHRGELEITSI
NQMYLNDGSLNVELLGRGFAWLDTGTHESLHEASSFVQTIENVQGLKVAC
LEEIAWSQGWLSDEKVYEIAKPMLKNDYGKYLVSLLDNETLRSSLQANK
>VF0420 membrane-bound lytic murein transglycosylase C precursor
MKKIILIASTCLLLTSCSRESIESTFGVNYDTTNRFAKNLAPLPGQFTKD
IKALDSLISSFNGNIEKRWGKKNLVTAGKRSYVKYTDGYLSRSQVDFTNG
RVTVRNGCWY
>VF2068 lipoprotein NlpD
MRKMIINLISIRLWLMAAVVSLLLSGCSMGPHRPAPVSSVNSSSSAYNGA
ERGSYRGSYYTVEKGDTLYFISYVTNKDVKELIAYNELKAPYMIHPGQKI
KLWGPKYIAPAYGSDGHSVTPSNSSSSSTATAVAVVPVATNKPAPKPKPT
TTSAKKTSSVQKESTKKVENSKPKEYVNSNKTITSSKPKPVAKPKPTPKP
KPKPVQQKSDKVDSWLWPTKGRIIAKFSTGDQGNKGIDIAGQRGQDIIST
AKGTVVYAGNALRGYGNLIIIKHNDDYLSAYAHNEALFVKEGQNVTAGQK
IASMGSSSTSSVRLHFEIRFRGKSVNPQRYLP
>VF0191 UDP-N-acetylglucosamine 4,6-dehydratase
MFKDKILLITGGTGSFGNAVLDRFLETDIKEIRIFSRDEKKQDDMRKKYN
SPKLKFYIGDVRDYNSILSASRGVDFVFHAAALKQVPSCEFHPMEAVKTN
VLGTENVLEACIANEVSRVVCLSTDKAVYPINAMGISKAMMEKVIVAKSR
NVDPNKTVISTTRYGNVMASRGSVIPLFLRQIMSGDAITITDPNMTRFMM
TLNDAVDLVLHAFIYGINGDIFVQKAPAATIDVLVQALKAITSKPEHEVN
VIGTRHGEKLYEALCSREEMFVAEDQGGYYRIPSDNRDLNYSQYVEEGEQ
DLSTIEDYNSHNTDRLDVDGMIELLHKLDFIADIEAGSLIVPEGV
>VF0149 glycosyltransferase
MKIALVMVHGRVHGHVGGAPRVFFDMANHLSFEGHEVLAVYNDSKEGSPY
YEVTNKVNLKNLALPIKFKGLWLYKAFREVIRSFAKLFNTDLRLNPVTKK
NQKRVGLALKSLIDDFKPDVTISYNVSDLVSLSYIEWKARNSIVMCHTDP
KRVYKGLANYERSIWQGADFIQVLLASYKDYLSKVINTNIEVIGNVVIEH
DEVNDLSAFRIIYLARIEKNKQQHLLIEAINKIPLNVRLGWQVVLYGSCN
DTEYSEFLINKINSYNLSDVIKLKGPTGKPFEELLNSSICAFPSAFEGFP
LALTEAMSLGLPCIGFQSCSGVNELLINNYNGFLVKGVEEFALQLEVLMK
SKERRSLMGSKARDSIECYSKESIYKKWKALIENKNVIV
>VF2523 periplasmic component of efflux system
MKKWTFFMLLLALLLFGSVIGFNMFKQQKIAEYMANRPEAEFPVTVETVE
PTLWTPTIEAIGFIEPNQGVTLTTEVNGIIDKISFDSGSQVKKGQVLVSL
DSKVEKANLKSTQARLPAAEAKYKRYKGLYKKGSISKEAYDEAEANYLSL
AADIESMKASIDRREIKAPFSGVIGIRNVYLGQYLQPSTDIVRLEDTSVM
RLRFTVPQTDISKINIGQEIDISVDSYPEDTFRGSISAIEPAVNIQSGLI
EVQADIPNNGGKLRSGMFAQAKIILPTLENQVVIPQTAITFTLYGDNVYI
VSEKDGVKRVQQHVVKVGERSKDIAHILEGVKAGDMVVTTGQVRLSNDAK
VRIVESNATTPPAETPML
>VF0459 prolipoprotein diacylglyceryl transferase
MSQGYLNFPHIDPVLIEIGPLAVRWYGLMYLFGFMFALWLANKRADKPNS
GWTRDQVSDLLFAGFLGVVIGGRVGYVLFYNFGYFLDNPLYLFEVWTGGM
SFHGGLLGVISAMLWYGYKNNRSFFTIADFVAPLVPFGLGAGRLGNFMNG
ELWGRVTDVPWAMVFPTGGPFPRHPSQLYEFALEGVVLFLILNWFIRKPR
PLGTVSGLFLFGYGTFRFLVEYVRQPDAQLGLFGDWISMGQILSLPMVIG
GLLMMLWAFKRNLYPSIEQPQSTTKKK
>VF1183 acriflavin resistance periplasmic protein
MQRLMKLSLLSSTLLLTACNPAPTETVVEIPNVVIKDINSNGVSDRLYLP
AVATAADRSHLSFRLSGEIKELNIKAGEIVKKGQVLAVLDKTDYNIDVDN
ARARYNVANSQYKRSKPLVDKGLLAKSQFDELAAQRQIALADLELAKLRL
SFTELKAPIDGVISRVSVEQFENIQVGQQIFNINNRDAVDIIVQVPDKLY
AKQPNKEIIESIKATVRLDSGESYSARIKEYTTEPDPDSGAYLVTLTMPM
PEDQFILDGMAVEVATSESEIRLSTQAGMVIPIEAIFNEDGDTIDLAEKY
VWLVDENNTVKKQKVVTTKATSSGLRVVEGLSTGDRIVIAGVSRLRDGMS
VNVINAEEKK
>VF0180 undecaprenyl-phosphatealpha-N-acetylglucosaminephosphotransferase
MINAYLFVFLVSFISLFIMRKVAKRIGLVDKPNERKHHKGVIPLIGGISI
FTTLCIGLLLFLPVTETLLMYLACAAVLVVLGAFDDYFDVSFKIRLIVQT
GISLVIIFAGGHSLHNLGFLMGSETIMLSSAVSGFITILGVIGAINAFNM
VDGIDGLLGGLASVTFAALATVFYYSGNDYLAHVCGLIVIAMVPYIMLNL
GFPLGRRFKVFMGDAGSMFIGFTVVWMLIRGSQEPAVIAFKPVTALWLIA
IPLMDMATIMIRRVRKGQSPFKPDREHLHHICQRLGLSSYMTLFLICTVA
LICAFFGIWADLNGVSESVMFFSFLALFGVYFMTISYIWRITTFVHKLFG
KRMSVQLQAEISK